{"cells":[{"cell_type":"code","source":["dbutils.fs.ls('dbfs:/FileStore/tables')"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"beeefed2-569a-4000-8f2b-66377ba38907"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[49]: [FileInfo(path='dbfs:/FileStore/tables/WEEK7ASS.ipynb', name='WEEK7ASS.ipynb', size=8974, modificationTime=1647880214000),\n FileInfo(path='dbfs:/FileStore/tables/WEEK_8_ASS___1_.ipynb', name='WEEK_8_ASS___1_.ipynb', size=1200916, modificationTime=1648561565000),\n FileInfo(path='dbfs:/FileStore/tables/accounts.zip', name='accounts.zip', size=5297592, modificationTime=1645025961000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltri/', name='clinicaltri/', size=0, modificationTime=0),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial/', name='clinicaltrial/', size=0, modificationTime=0),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2019.csv', name='clinicaltrial_2019.csv', size=42400056, modificationTime=1651832598000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2019_csv', name='clinicaltrial_2019_csv', size=42400056, modificationTime=1648053134000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2019_csv-1.gz', name='clinicaltrial_2019_csv-1.gz', size=10060669, modificationTime=1651709595000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2019_csv.gz', name='clinicaltrial_2019_csv.gz', size=10060669, modificationTime=1648117393000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020.csv', name='clinicaltrial_2020.csv', size=46318151, modificationTime=1651832600000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020_csv-1.gz', name='clinicaltrial_2020_csv-1.gz', size=10981608, modificationTime=1651709571000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020_csv.gz', name='clinicaltrial_2020_csv.gz', size=10981608, modificationTime=1648054179000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021.csv', name='clinicaltrial_2021.csv', size=50359696, modificationTime=1651832602000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021_csv-1.gz', name='clinicaltrial_2021_csv-1.gz', size=11921810, modificationTime=1651709558000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021_csv.gz', name='clinicaltrial_2021_csv.gz', size=11921810, modificationTime=1648054183000),\n FileInfo(path='dbfs:/FileStore/tables/devicestatus-1.zip', name='devicestatus-1.zip', size=23873574, modificationTime=1645031748000),\n FileInfo(path='dbfs:/FileStore/tables/devicestatus.zip', name='devicestatus.zip', size=23873574, modificationTime=1645030583000),\n FileInfo(path='dbfs:/FileStore/tables/hive_assi.sql', name='hive_assi.sql', size=3698, modificationTime=1650620262000),\n FileInfo(path='dbfs:/FileStore/tables/json_activations-1.zip', name='json_activations-1.zip', size=8411369, modificationTime=1645006486000),\n FileInfo(path='dbfs:/FileStore/tables/json_activations-2.zip', name='json_activations-2.zip', size=8411369, modificationTime=1645007694000),\n FileInfo(path='dbfs:/FileStore/tables/json_activations.zip', name='json_activations.zip', size=8411369, modificationTime=1645006330000),\n FileInfo(path='dbfs:/FileStore/tables/letter_frequencies.txt', name='letter_frequencies.txt', size=2593894, modificationTime=1645887857000),\n FileInfo(path='dbfs:/FileStore/tables/logs.zip', name='logs.zip', size=18168065, modificationTime=1645617549000),\n FileInfo(path='dbfs:/FileStore/tables/mesh-1.csv', name='mesh-1.csv', size=5295548, modificationTime=1651707552000),\n FileInfo(path='dbfs:/FileStore/tables/mesh-2.csv', name='mesh-2.csv', size=5295548, modificationTime=1651709533000),\n FileInfo(path='dbfs:/FileStore/tables/mesh.csv', name='mesh.csv', size=5295548, modificationTime=1651704959000),\n FileInfo(path='dbfs:/FileStore/tables/meshfile/', name='meshfile/', size=0, modificationTime=0),\n FileInfo(path='dbfs:/FileStore/tables/my_mesh.csv/', name='my_mesh.csv/', size=0, modificationTime=0),\n FileInfo(path='dbfs:/FileStore/tables/mymesh/', name='mymesh/', size=0, modificationTime=0),\n FileInfo(path='dbfs:/FileStore/tables/negative_words.csv', name='negative_words.csv', size=49548, modificationTime=1651069542000),\n FileInfo(path='dbfs:/FileStore/tables/pharma-1.csv', name='pharma-1.csv', size=678999, modificationTime=1651707528000),\n FileInfo(path='dbfs:/FileStore/tables/pharma-2.csv', name='pharma-2.csv', size=678999, modificationTime=1651709517000),\n FileInfo(path='dbfs:/FileStore/tables/pharma.csv', name='pharma.csv', size=678999, modificationTime=1651704940000),\n FileInfo(path='dbfs:/FileStore/tables/pharmafile/', name='pharmafile/', size=0, modificationTime=0),\n FileInfo(path='dbfs:/FileStore/tables/pharmfile/', name='pharmfile/', size=0, modificationTime=0),\n FileInfo(path='dbfs:/FileStore/tables/positive_words.csv', name='positive_words.csv', size=21105, modificationTime=1651068903000),\n FileInfo(path='dbfs:/FileStore/tables/webpage.zip', name='webpage.zip', size=1582, modificationTime=1646216615000)]","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[49]: [FileInfo(path='dbfs:/FileStore/tables/WEEK7ASS.ipynb', name='WEEK7ASS.ipynb', size=8974, modificationTime=1647880214000),\n FileInfo(path='dbfs:/FileStore/tables/WEEK_8_ASS___1_.ipynb', name='WEEK_8_ASS___1_.ipynb', size=1200916, modificationTime=1648561565000),\n FileInfo(path='dbfs:/FileStore/tables/accounts.zip', name='accounts.zip', size=5297592, modificationTime=1645025961000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltri/', name='clinicaltri/', size=0, modificationTime=0),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial/', name='clinicaltrial/', size=0, modificationTime=0),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2019.csv', name='clinicaltrial_2019.csv', size=42400056, modificationTime=1651832598000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2019_csv', name='clinicaltrial_2019_csv', size=42400056, modificationTime=1648053134000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2019_csv-1.gz', name='clinicaltrial_2019_csv-1.gz', size=10060669, modificationTime=1651709595000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2019_csv.gz', name='clinicaltrial_2019_csv.gz', size=10060669, modificationTime=1648117393000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020.csv', name='clinicaltrial_2020.csv', size=46318151, modificationTime=1651832600000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020_csv-1.gz', name='clinicaltrial_2020_csv-1.gz', size=10981608, modificationTime=1651709571000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2020_csv.gz', name='clinicaltrial_2020_csv.gz', size=10981608, modificationTime=1648054179000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021.csv', name='clinicaltrial_2021.csv', size=50359696, modificationTime=1651832602000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021_csv-1.gz', name='clinicaltrial_2021_csv-1.gz', size=11921810, modificationTime=1651709558000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021_csv.gz', name='clinicaltrial_2021_csv.gz', size=11921810, modificationTime=1648054183000),\n FileInfo(path='dbfs:/FileStore/tables/devicestatus-1.zip', name='devicestatus-1.zip', size=23873574, modificationTime=1645031748000),\n FileInfo(path='dbfs:/FileStore/tables/devicestatus.zip', name='devicestatus.zip', size=23873574, modificationTime=1645030583000),\n FileInfo(path='dbfs:/FileStore/tables/hive_assi.sql', name='hive_assi.sql', size=3698, modificationTime=1650620262000),\n FileInfo(path='dbfs:/FileStore/tables/json_activations-1.zip', name='json_activations-1.zip', size=8411369, modificationTime=1645006486000),\n FileInfo(path='dbfs:/FileStore/tables/json_activations-2.zip', name='json_activations-2.zip', size=8411369, modificationTime=1645007694000),\n FileInfo(path='dbfs:/FileStore/tables/json_activations.zip', name='json_activations.zip', size=8411369, modificationTime=1645006330000),\n FileInfo(path='dbfs:/FileStore/tables/letter_frequencies.txt', name='letter_frequencies.txt', size=2593894, modificationTime=1645887857000),\n FileInfo(path='dbfs:/FileStore/tables/logs.zip', name='logs.zip', size=18168065, modificationTime=1645617549000),\n FileInfo(path='dbfs:/FileStore/tables/mesh-1.csv', name='mesh-1.csv', size=5295548, modificationTime=1651707552000),\n FileInfo(path='dbfs:/FileStore/tables/mesh-2.csv', name='mesh-2.csv', size=5295548, modificationTime=1651709533000),\n FileInfo(path='dbfs:/FileStore/tables/mesh.csv', name='mesh.csv', size=5295548, modificationTime=1651704959000),\n FileInfo(path='dbfs:/FileStore/tables/meshfile/', name='meshfile/', size=0, modificationTime=0),\n FileInfo(path='dbfs:/FileStore/tables/my_mesh.csv/', name='my_mesh.csv/', size=0, modificationTime=0),\n FileInfo(path='dbfs:/FileStore/tables/mymesh/', name='mymesh/', size=0, modificationTime=0),\n FileInfo(path='dbfs:/FileStore/tables/negative_words.csv', name='negative_words.csv', size=49548, modificationTime=1651069542000),\n FileInfo(path='dbfs:/FileStore/tables/pharma-1.csv', name='pharma-1.csv', size=678999, modificationTime=1651707528000),\n FileInfo(path='dbfs:/FileStore/tables/pharma-2.csv', name='pharma-2.csv', size=678999, modificationTime=1651709517000),\n FileInfo(path='dbfs:/FileStore/tables/pharma.csv', name='pharma.csv', size=678999, modificationTime=1651704940000),\n FileInfo(path='dbfs:/FileStore/tables/pharmafile/', name='pharmafile/', size=0, modificationTime=0),\n FileInfo(path='dbfs:/FileStore/tables/pharmfile/', name='pharmfile/', size=0, modificationTime=0),\n FileInfo(path='dbfs:/FileStore/tables/positive_words.csv', name='positive_words.csv', size=21105, modificationTime=1651068903000),\n FileInfo(path='dbfs:/FileStore/tables/webpage.zip', name='webpage.zip', size=1582, modificationTime=1646216615000)]"]}}],"execution_count":0},{"cell_type":"code","source":["dbutils.fs.ls('dbfs:/FileStore/tables/clinicaltrial_2021.csv')"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"3415aa2b-924f-4523-947c-26d7e3e8e475"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[50]: [FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021.csv', name='clinicaltrial_2021.csv', size=50359696, modificationTime=1651832602000)]","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[50]: [FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2021.csv', name='clinicaltrial_2021.csv', size=50359696, modificationTime=1651832602000)]"]}}],"execution_count":0},{"cell_type":"code","source":["for data in dbutils.fs.head('dbfs:/FileStore/tables/clinicaltrial_2021.csv').splitlines():\n    print(data)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"c04d0392-2349-4e6f-b8f2-7d240933d244"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"[Truncated to first 65536 bytes]\nId|Sponsor|Status|Start|Completion|Type|Submission|Conditions|Interventions\nNCT02758028|The University of Hong Kong|Recruiting|Aug 2005|Nov 2021|Interventional|Apr 2016||\nNCT02751957|Duke University|Completed|Jul 2016|Jul 2020|Interventional|Apr 2016|Autistic Disorder,Autism Spectrum Disorder|\nNCT02758483|Universidade Federal do Rio de Janeiro|Completed|Mar 2017|Jan 2018|Interventional|Apr 2016|Diabetes Mellitus|\nNCT02759848|Istanbul Medeniyet University|Completed|Jan 2012|Dec 2014|Observational|May 2016|Tuberculosis,Lung Diseases,Pulmonary Disease|\nNCT02758860|University of Roma La Sapienza|Active, not recruiting|Jun 2016|Sep 2020|Observational [Patient Registry]|Apr 2016|Diverticular Diseases,Diverticulum,Diverticulosis|\nNCT02757209|Consorzio Futuro in Ricerca|Completed|Apr 2016|Jan 2018|Interventional|Apr 2016|Asthma|Fluticasone,Xhance,Budesonide,Formoterol Fumarate,Salmeterol Xinafoate\nNCT02752438|Ankara University|Unknown status|May 2016|Jul 2017|Observational [Patient Registry]|Apr 2016|Hypoventilation|\nNCT02753543|Ruijin Hospital|Unknown status|Nov 2015|Nov 2019|Interventional|Apr 2016|Lymphoma|\nNCT02757508|Washington University School of Medicine|Completed|Mar 2016|Jul 2017|Interventional|Apr 2016||Vitamins\nNCT02753530|Orphazyme|Completed|Aug 2017|Jan 2021|Interventional|Apr 2016|Myositis|\nNCT02754817|Novo Nordisk A/S|Completed|Apr 2016|Oct 2016|Observational|Apr 2016|Diabetes Mellitus|Liraglutide,Xultophy\nNCT02759276|Daniel Alexandre Bottino|Completed|May 2015|Dec 2015|Observational|Apr 2016|Hypertension|\nNCT02750956|Bulent Ecevit University|Completed|Jun 2015|Mar 2016|Observational|Apr 2016|Periodontal Diseases|\nNCT02752113|Institut für Pharmakologie und Präventive Medizin|Completed|Apr 2016|May 2019|Interventional|Apr 2016|Diabetes Mellitus|Metformin,Empagliflozin,Linagliptin\nNCT02752698|The Third Xiangya Hospital of Central South University|Active, not recruiting|Jan 2015|Dec 2021|Interventional|Jun 2015|Appendicitis,Stomach Ulcer,Cholecystolithiasis,Cholelithiasis,Gallstones|\nNCT02755779|Tel Aviv Medical Center|Unknown status|Jun 2016|Jun 2017|Observational|Apr 2016||\nNCT02750384|Medicines for Malaria Venture|Terminated|May 2016|Jul 2016|Interventional|Apr 2016||\nNCT02754609|James Cook University, Queensland, Australia|Completed|Sep 2016|Oct 2019|Interventional|Apr 2016|Hookworm Infections,Celiac Disease|\nNCT02755701|Soonchunhyang University Hospital|Unknown status|Jul 2016|Dec 2018|Interventional|Apr 2016|Ascites|\nNCT02751762|Member Companies of the Opioid PMR Consortium|Recruiting|Nov 2017|Oct 2022|Observational|Apr 2016|Chronic Pain,Substance-Related Disorders,Opioid-Related Disorders,Narcotic-Related Disorders,Behavior|\nNCT02756299|Marmara University|Completed|Jun 2014|Apr 2015|Interventional|Apr 2016|Sleep Apnea Syndromes,Sleep Apnea|\nNCT02750709|Cycle Pharmaceuticals Ltd.|Completed|Oct 2015|Jan 2016|Interventional|Apr 2016|Tyrosinemias|Nitisinone\nNCT02753907|Yonsei University|Completed|Jun 2015||Interventional|Apr 2016||\nNCT02755467|Cutera Inc.|Completed|May 2016|Apr 2017|Interventional|Apr 2016|Hemangioma|\nNCT02755298|University of Zurich|Completed|Oct 2016|Nov 2020|Interventional|Mar 2016|Hypertension|Acetazolamide\nNCT02759614|Guangdong Association of Clinical Trials|Unknown status|Apr 2016|Jun 2019|Interventional|Mar 2016|Carcinoma|Bevacizumab,Erlotinib Hydrochloride\nNCT02752815|Ruijin Hospital|Unknown status|Apr 2016|Jun 2020|Interventional|Apr 2016|Lymphoma|Prednisone,Cyclophosphamide,Rituximab,Vincristine,Epirubicin\nNCT02757131|The Cleveland Clinic|Completed|Jul 2016|Jul 2017|Interventional|Apr 2016|Iatrogenic Disease|\nNCT02758704|St. Justine's Hospital|Completed|Oct 2015|Jun 2021|Interventional|Apr 2016||\nNCT02750501|Alcresta Therapeutics, Inc.|Completed|Jul 2016|Mar 2017|Interventional|Apr 2016|Cystic Fibrosis,Fibrosis|\nNCT02759913|Iron Horse Diagnostics, Inc.|Unknown status|Jan 2015|Dec 2016|Observational|Apr 2016|Motor Neuron Disease,Amyotrophic Lateral Sclerosis,Sclerosis|\nNCT02752724|VA Puget Sound Health Care System|Completed|Mar 2016|Apr 2018|Interventional|Mar 2016|Depressive Disorder,Depression|Ketamine,Methohexital\nNCT02758444|University of Colorado, Denver|Completed|Nov 2015|Feb 2019|Interventional|Apr 2016||Micronutrients,Trace Elements\nNCT02758067|H. Lundbeck A/S|Withdrawn|Jun 2016||Interventional|Apr 2016|Schizophrenia|Risperidone,Brexpiprazole\nNCT02759341|Ospedale San Giovanni Bellinzona|Completed|Feb 2016|Nov 2017|Interventional|Apr 2016|Myocardial Infarction,Cardiomyopathies,Microvascular Angina,Takotsubo Cardiomyopathy,Syndrome,Infarction|\nNCT02753803|Dong-A ST Co., Ltd.|Completed|Jul 2016|Mar 2017|Interventional|Apr 2016||Pioglitazone\nNCT02752490|The University of Texas Health Science Center, Houston|Completed|Apr 2016|Jul 2016|Interventional|Apr 2016||\nNCT02759562|Gilead Sciences|Terminated|Nov 2016|Jul 2017|Interventional|Apr 2016|Cystic Fibrosis,Fibrosis|\nNCT02758262|Laval University|Unknown status|Apr 2016|Dec 2017|Interventional|Apr 2016|Hyperphagia|\nNCT02754258|Children's Hospital of Eastern Ontario|Unknown status|Jan 2017|Dec 2018|Interventional|Apr 2016||Methylphenidate\nNCT02755207|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|Unknown status|Apr 2016|Dec 2020|Observational|Mar 2016|Acute Coronary Syndrome,Syndrome|\nNCT02759900|The Skin Center Dermatology Group|Recruiting|Jan 2016|Jan 2023|Interventional|Apr 2016|Molluscum Contagiosum,Keratosis,Bowens Disease,Rosacea,Skin Diseases|\nNCT02752581|Mert Özcan|Completed|Jan 2009|Apr 2013|Interventional|Apr 2016|Hemarthrosis|\nNCT02759796|Instituto de Investigación Hospital Universitario La Paz|Completed|Nov 2015|Apr 2017|Interventional|Apr 2016|Necrosis,Neovascularization,Fat Necrosis|\nNCT02754063|University Hospital, Grenoble|Active, not recruiting|Jun 2016|Apr 2022|Interventional|Apr 2016|Brain Injuries,Wounds and Injuries|3\nNCT02750917|Foisor Orthopedics Clinical Hospital|Completed|Sep 2014|Mar 2015|Interventional|Feb 2016|Pain|Etoricoxib,Lornoxicam\nNCT02753569|Institute of Cancer Research, United Kingdom|Completed|May 2016|May 2020|Observational|Apr 2016||\nNCT02751255|VU University Medical Center|Active, not recruiting|Jul 2016|Mar 2022|Interventional|Apr 2016|Multiple Myeloma,Neoplasms|Tretinoin\nNCT02751528|NantBioScience, Inc.|Unknown status|Dec 2016|Dec 2020|Interventional|Apr 2016|Breast Neoplasms|Vaccines\nNCT02751619|University of Campania Luigi Vanvitelli|Completed|Jan 2013|Dec 2015|Interventional|Apr 2016|Pain|Lidocaine\nNCT02757833|Lawson Health Research Institute|Withdrawn|Feb 2019|Feb 2019|Interventional|Apr 2016|Depression,Depressive Disorder|\nNCT02750761|Merck Sharp & Dohme Corp.|Completed|May 2016|Dec 2018|Interventional|Apr 2016|Infections,Bacterial Infections,Gram-Positive Bacterial Infections|Tedizolid phosphate,Tedizolid,Oxazolidinones\nNCT02752594|Sharda University|Completed|Apr 2015|Apr 2015|Interventional|Apr 2016|Dental Caries|\nNCT02753452|Holland Bloorview Kids Rehabilitation Hospital|Unknown status|May 2015|Mar 2020|Interventional|Apr 2016||\nNCT02752763|Niğde State Hospital|Completed|Oct 2015|Mar 2016|Interventional|Mar 2016|Dry Eye Syndromes,Keratoconjunctivitis Sicca|Dextrans,Povidone,Ophthalmic Solutions,Lubricant Eye Drops\nNCT02753816|Spectrum Health Hospitals|Terminated|Apr 2016|Dec 2019|Interventional|Apr 2016|Burns|Tranexamic Acid\nNCT02751294|GlaxoSmithKline|Completed|May 2016|Aug 2016|Interventional|Apr 2016|Malaria|Tafenoquine\nNCT02756429|Hospices Civils de Lyon|Completed|Feb 2014|Jan 2018|Interventional|Apr 2016|Atrial Fibrillation|\nNCT02750163|Università Politecnica delle Marche|Completed|Jul 2017|Jun 2019|Observational|Apr 2016|Shock|Acetaminophen\nNCT02751905|Biogen|Completed|Apr 2016|May 2016|Interventional|Apr 2016|Neuralgia|\nNCT02753153|University of Liege|Completed|May 2011|May 2015|Interventional|Apr 2016|Tooth Loss|\nNCT02750891|Sumitomo Dainippon Pharma Co., Ltd.|Completed|Apr 2016|Jan 2020|Interventional|Apr 2016|Glioblastoma,Glioma,Diffuse Intrinsic Pontine Glioma|\nNCT02751073|Mayo Clinic|Completed|Feb 2016|Jul 2018|Observational|Feb 2016|Infections,Communicable Diseases,Urinary Tract Infections,Prolapse,Pelvic Organ Prolapse|\nNCT02753114|University of British Columbia|Completed|Nov 2017|May 2018|Interventional|Apr 2016|Acute Pain|Ketamine\nNCT02752516|Chia Tai Tianqing Pharmaceutical Group Co., Ltd.|Unknown status|Apr 2016|Dec 2017|Interventional|Apr 2016||\nNCT02752269|Medical University of Graz|Completed|Oct 2014|Jun 2019|Observational|Nov 2015|Sjogrens Syndrome,Hypertension,Vascular Diseases,Syndrome|\nNCT02754713|Hippocration General Hospital|Recruiting|Sep 2009|Dec 2025|Observational|Apr 2016|Pericarditis|\nNCT02759770|Beijing Anzhen Hospital|Completed|Jul 2017|Sep 2017|Observational|Apr 2016|Respiratory Distress Syndrome,Acute Lung Injury|\nNCT02755129|Medtronic BRC|Completed|Sep 2016|Jul 2017|Interventional|Mar 2016|Frailty|\nNCT02754674|Samsung Medical Center|Completed|May 2014|Dec 2017|Interventional|Feb 2015|Rupture|\nNCT02757521|Washington University School of Medicine|Terminated|Mar 2016|Dec 2016|Interventional|Apr 2016|Disease,Depression,Depressive Disorder,Bipolar Disorder|Nitrous Oxide\nNCT02750774|University of Modena and Reggio Emilia|Unknown status|Dec 2015|Dec 2016|Interventional|Apr 2016|Diabetes,Obesity,Pregnancy Complications,Fetal Macrosomia,Overweight,Birth Weight|\nNCT02754739|Samsung Medical Center|Completed|Apr 2014|Aug 2017|Interventional|Apr 2016|Diabetes Mellitus,Prediabetic State|Pravastatin\nNCT02758808|University of Michigan|Recruiting|Mar 2016|Oct 2023|Observational [Patient Registry]|Apr 2016|Lung Diseases,Pulmonary Fibrosis,Idiopathic Pulmonary Fibrosis,Fibrosis|\nNCT02751840|Tel Hai College|Completed|Oct 2014|Apr 2016|Interventional|Apr 2016|Asymptomatic Diseases|Caffeine\nNCT02752451|University of Arizona|Completed|Mar 2015|Apr 2015|Interventional|Apr 2016||\nNCT02757599|Rigshospitalet, Denmark|Completed|Aug 2016|Jun 2017|Interventional|Apr 2016||\nNCT02753894|Astellas Pharma Inc|Completed|Jan 2008|Jun 2008|Interventional|Mar 2016|Kidney Diseases,Renal Insufficiency,Hyperphosphatemia|\nNCT02757638|Texas A&M University|Active, not recruiting|Oct 2015|Oct 2021|Interventional|Feb 2016|Weight Loss|\nNCT02757378|Kevin Farrell|Completed|May 2015|Sep 2015|Interventional|Apr 2016|Back Pain,Low Back Pain|\nNCT02751489|Bayer|Completed|May 2016|May 2016|Interventional|Apr 2016|Dermatitis|\nNCT02759315|Merck Sharp & Dohme Corp.|Terminated|May 2016|Nov 2017|Interventional|Apr 2016|Hepatitis A,Hepatitis C,Hepatitis|Uprifosbuvir,Ruzasvir\nNCT02754895|Massachusetts General Hospital|Completed|Oct 2014|May 2017|Interventional|Apr 2016|Acute Coronary Syndrome,Syndrome|\nNCT02750475|Bayer|Completed|May 2016|May 2016|Interventional|Apr 2016|Dermatitis|Sunscreening Agents\nNCT02755064|Adil Bharucha|Completed|Jun 2010|Nov 2013|Interventional|Apr 2016|Diabetes Mellitus|Erythromycin,Erythromycin Estolate,Erythromycin Ethylsuccinate,Erythromycin stearate,Erythromycin lactobionate\nNCT02758002|University of California, San Diego|Withdrawn|Jan 2016|Dec 2018|Interventional|Apr 2016|Atrial Fibrillation|\nNCT02755142|medac GmbH|Completed|Feb 2000|Jun 2001|Interventional|Apr 2016|Glioma,Brain Neoplasms|Aminolevulinic Acid\nNCT02756364|Millennium Pharmaceuticals, Inc.|Completed|Jul 2016|Nov 2019|Interventional|Apr 2016|Breast Neoplasms|Fulvestrant\nNCT02759484|Rush University Medical Center|Unknown status|Mar 2015|Mar 2019|Interventional|Dec 2015|Hypertension,Diabetes Mellitus,Hyperglycemia|\nNCT02752061|Harvard School of Public Health (HSPH)|Completed|May 2016|Jul 2020|Interventional|Apr 2016||\nNCT02756598|Aarhus University Hospital|Completed|Jan 2015|Jun 2018|Interventional|Dec 2015||Sufentanil,Dsuvia,Propofol\nNCT02755727|Royal Devon and Exeter NHS Foundation Trust|Completed|Mar 2016|Sep 2017|Interventional|Apr 2016|Tennis Elbow|\nNCT02754882|Samsung Bioepis Co., Ltd.|Completed|Jul 2016|Oct 2018|Interventional|Mar 2016|Lung Neoplasms,Carcinoma|Paclitaxel,Bevacizumab,Carboplatin\nNCT02754778|Martin-Luther-Universität Halle-Wittenberg|Completed|Apr 2016|Mar 2021|Interventional|Apr 2016|Pre-Eclampsia,HELLP Syndrome,Syndrome|\nNCT02758171|Boehringer Ingelheim|Completed|May 2016|Aug 2016|Interventional|Apr 2016||Empagliflozin,Linagliptin\nNCT02755376|Samsung Medical Center|Completed|Jan 2014|Dec 2018|Interventional|Feb 2015||Hyaluronic Acid\nNCT02759016|Boehringer Ingelheim|Completed|Jun 2016|Jul 2019|Interventional|Apr 2016|Leukemia|BI 836826\nNCT02758457|University of Bologna|Completed|Jan 2008|Apr 2015|Interventional|Apr 2016||\nNCT02755519|Chongqing Medical University|Completed|May 2014|Oct 2016|Observational|Apr 2016|Hyperaldosteronism|\nNCT02758782|Charite University, Berlin, Germany|Completed|Sep 2016|Jan 2021|Interventional|Apr 2016|Spondylitis|Celecoxib,Golimumab\nNCT02756806|Cutera Inc.|Completed|Apr 2016|Sep 2016|Interventional|Apr 2016||\nNCT02756156|Kahramanmaras Sutcu Imam University|Unknown status|Apr 2016|Aug 2016|Observational|Mar 2016|Humeral Fractures|\nNCT02759458|Rush University Medical Center|Completed|Nov 2013|Jan 2017|Interventional|Apr 2016|Rotator Cuff Injuries|\nNCT02750982|Brown, Theodore R., M.D., MPH|Completed|Jul 2016|Aug 2018|Interventional|Apr 2016|Parkinson Disease,Multiple Sclerosis,Alzheimer Disease,Brain Injuries,Spinal Cord Injuries,Motor Neuron Disease,Amyotrophic Lateral Sclerosis,Huntington Disease,Sclerosis,Wounds and Injuries|\nNCT02751502|NYU Langone Health|Terminated|Jan 2017|Feb 2021|Interventional|Apr 2016|Hemiplegia|\nNCT02752087|Eli Lilly and Company|Completed|Apr 2016|May 2016|Interventional|Apr 2016||\nNCT02756858|Anavex Life Sciences Corp.|Completed|Mar 2016|Nov 2020|Interventional|Mar 2016|Alzheimer Disease|\nNCT02758249|Konkuk University Medical Center|Completed|Jan 2016|Jan 2016|Interventional|Feb 2016||Propofol,Sevoflurane\nNCT02754570|University of Colorado, Denver|Completed|Jul 2016|Feb 2018|Interventional|Apr 2016|Glaucoma,Ocular Hypertension,Hypertension|Pilocarpine\nNCT02754102|Bayer|Completed|May 2016|May 2016|Interventional|Apr 2016|Dermatitis|Sunscreening Agents\nNCT02751593|Peking University People's Hospital|Unknown status|Jan 2016|Dec 2017|Interventional|Apr 2016|Thrombocytopenia,Purpura|Dexamethasone\nNCT02757014|Bayer|Completed|Oct 2015|Oct 2015|Interventional|Apr 2016||\nNCT02753062|Asan Medical Center|Recruiting|Aug 2015|Aug 2023|Interventional|Apr 2016|Lymphoma|Rituximab,Bendamustine Hydrochloride\nNCT02752425|Hospices Civils de Lyon|Completed|May 2016|May 2018|Interventional|Apr 2016|Speech Disorders|\nNCT02757300|Marienhospital Osnabrück|Unknown status|May 2016|Jul 2017|Interventional|Apr 2016|Pharyngitis|\nNCT02754180|Peking Union Medical College Hospital|Unknown status|Mar 2016|Mar 2021|Interventional|Apr 2016|Adenocarcinoma,Pancreatic Neoplasms|Gemcitabine\nNCT02752321|Northwell Health|Terminated|Aug 2016|Dec 2017|Interventional|Apr 2016||\nNCT02753595|Eisai Inc.|Terminated|Jul 2016|Aug 2019|Interventional|Apr 2016|Breast Neoplasms|\nNCT02755246|Charite University, Berlin, Germany|Completed|Apr 2016|Sep 2016|Interventional|Apr 2016|Cognitive Dysfunction|\nNCT02754115|Tata Memorial Centre|Recruiting|Apr 2016|Jan 2022|Observational|Mar 2016|Peritoneal Diseases|\nNCT02756897|M.D. Anderson Cancer Center|Active, not recruiting|Jul 2016|Jul 2024|Interventional|Apr 2016|Lymphoma,Leukemia|Venetoclax\nNCT02752334|Magrabi Eye & Ear Hospital|Completed|Sep 2015|Mar 2019|Interventional|Mar 2016||Magnesium Sulfate,Bupivacaine\nNCT02754791|Shaare Zedek Medical Center|Unknown status|May 2016|May 2017|Interventional|Apr 2016||\nNCT02754128|Holland Bloorview Kids Rehabilitation Hospital|Completed|Jun 2016|Oct 2017|Interventional|Apr 2016|Cerebral Palsy|\nNCT02751190|Umeå University|Completed|Sep 2013|Feb 2017|Observational [Patient Registry]|Apr 2016|Chronic Pain,Hernia|\nNCT02751645|Oregon Health and Science University|Unknown status|Jun 2016|May 2020|Interventional|Apr 2016||\nNCT02758184|Duke University|Terminated|Jun 2016|May 2018|Interventional|Apr 2016||\nNCT02751892|University of East Anglia|Completed|Oct 2013|Sep 2014|Interventional|Apr 2016|Colorectal Neoplasms|\nNCT02755324|Leiden University|Completed|Oct 2016|Jan 2019|Interventional|Apr 2016|Schistosomiasis|\nNCT02758886|Washington State University|Completed|Apr 2014||Interventional|Apr 2016|Stress|\nNCT02750072|Fraser Orthopaedic Research Society|Active, not recruiting|Sep 2016|Apr 2023|Interventional|Apr 2016|Patellofemoral Pain Syndrome,Fractures,Tibial Fractures|\nNCT02750332|Cycle Pharmaceuticals Ltd.|Completed|Nov 2015|Jan 2016|Interventional|Apr 2016|Tyrosinemias|Nitisinone\nNCT02752529|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine|Unknown status|Mar 2016||Interventional|Mar 2016|Liver Cirrhosis|Tacrolimus\nNCT02759939|Dartmouth-Hitchcock Medical Center|Completed|Jul 2016|Jul 2017|Interventional|Feb 2016||\nNCT02757157|European Respiratory Society|Terminated|Oct 2016|Jan 2020|Interventional|Apr 2016|Lung Diseases,Pulmonary Disease|\nNCT02759627|Istanbul University|Completed|Nov 2014|Mar 2016|Interventional|Apr 2016|Stroke|\nNCT02752412|Sanofi|Completed|May 2016|Oct 2018|Interventional|Apr 2016|Diabetes Mellitus|Insulin,Metformin,Insulin Glargine,Lixisenatide\nNCT02756988|Bayer|Completed|Oct 2015|Oct 2015|Interventional|Apr 2016||\nNCT02751203|Lara McKenzie|Completed|Apr 2016|Dec 2017|Interventional|Mar 2016||\nNCT02753946|Nabriva Therapeutics AG|Completed|Apr 2016|May 2017|Interventional|Apr 2016|Infections,Communicable Diseases,Urinary Tract Infections,Pyelonephritis|Tazobactam,Piperacillin,Fosfomycin\nNCT02755480|University Health Network, Toronto|Terminated|Feb 2015|Feb 2017|Interventional|Mar 2015||\nNCT02753257|Valtari Bio|Unknown status|Sep 2016|Dec 2019|Observational|Apr 2016|Stroke|\nNCT02758691|Virginia Polytechnic Institute and State University|Completed|Dec 2015|May 2017|Interventional|Apr 2016||Insulin\nNCT02755623|Centre hospitalier de Ville-Evrard, France|Unknown status|May 2015|Dec 2018|Interventional|Apr 2016|Hallucinations,Schizophrenia|\nNCT02756234|Lancaster General Hospital|Completed|May 2016|Aug 2018|Observational|Apr 2016|Coronary Artery Disease|\nNCT02756091|University Hospital Inselspital, Berne|Recruiting|Aug 2016|May 2022|Observational [Patient Registry]|Apr 2016|Cerebrovascular Disorders|\nNCT02753491|Marmara University|Completed|Oct 2015|Mar 2016|Interventional|Apr 2016||\nNCT02752737|Medtronic Cardiac Rhythm and Heart Failure|Recruiting|May 2016|Dec 2024|Observational [Patient Registry]|Apr 2016|Atrial Fibrillation|\nNCT02758925|University Hospital, Caen|Unknown status|Jun 2016|Dec 2018|Interventional|Apr 2016|Lymphoma|Cytarabine,Rituximab,Bendamustine Hydrochloride\nNCT02751723|Florian Lordick, MD|Unknown status|Sep 2014|Oct 2019|Observational|Apr 2016||\nNCT02751931|Astellas Pharma Europe B.V.|Completed|Jun 2016|May 2019|Interventional|Apr 2016|Urinary Bladder|Mirabegron\nNCT02758847|Rabih A. Chaer|Recruiting|Sep 2016|Dec 2022|Interventional|Apr 2016|Ischemia|Paclitaxel,Albumin-Bound Paclitaxel\nNCT02757807|Eco Fusion|Unknown status|Jul 2016|Dec 2016|Interventional|Apr 2016|Erectile Dysfunction|\nNCT02755220|Shanghai Cingularbio Co. Ltd|Completed|Jan 2016|Apr 2019|Interventional|Apr 2016||\nNCT02758548|Novartis Pharmaceuticals|Completed|Mar 2016|May 2016|Interventional|Mar 2016||\nNCT02756845|Amgen|Recruiting|Aug 2017|Jun 2024|Interventional|Dec 2015|Neoplasms|Talimogene laherparepvec\nNCT02750605|Skane University Hospital|Active, not recruiting|Feb 2016|Dec 2021|Interventional|Jan 2016|Vascular Diseases,Peripheral Vascular Diseases,Peripheral Arterial Disease,Ischemia|\nNCT02756702|Aesculap AG|Active, not recruiting|Mar 2016|Dec 2022|Observational|Apr 2016|Osteoarthritis|\nNCT02752945|King's College London|Completed|Apr 2016|Dec 2016|Interventional|Apr 2016|Depression,Depressive Disorder,Anxiety Disorders|\nNCT02759952|STZ eyetrial|Enrolling by invitation|Jan 2013|Dec 2025|Observational|Apr 2016|Retinitis,Retinitis Pigmentosa|\nNCT02754661|Medtronic - MITG|Completed|Sep 2016|Aug 2018|Interventional|Apr 2016|Colorectal Neoplasms|\nNCT02755441|Nils Hoyer|Recruiting|Apr 2016|Dec 2024|Observational|Apr 2016|Pulmonary Fibrosis,Idiopathic Pulmonary Fibrosis,Fibrosis|\nNCT02750098|Sheba Medical Center|Unknown status|May 2016|Mar 2018|Interventional|Apr 2016|Diabetes Mellitus|\nNCT02753179|Hospices Civils de Lyon|Completed|May 2016|Jan 2017|Interventional|Apr 2016|Vestibular Diseases|\nNCT02758509|Parc de Salut Mar|Completed|Jan 2010|Oct 2017|Observational|Apr 2016|Hepatitis C,Hepatitis|Interferons,Ritonavir,Ribavirin,Interferon-alpha,Interferon alpha-2,Sofosbuvir,Peginterferon alfa-2a,Ledipasvir,Simeprevir\nNCT02751970|Universidad de Valparaiso|Unknown status|Apr 2014|Apr 2018|Interventional|Apr 2016|Dental Caries|\nNCT02753712|Mundipharma Research Limited|Completed|Jun 2016|Aug 2017|Interventional|Apr 2016|Asthma|Fluticasone,Xhance,Formoterol Fumarate\nNCT02751151|Inova Health Care Services|Completed|Feb 2016|May 2021|Interventional|Mar 2016|Skin Neoplasms|Aminolevulinic Acid\nNCT02757716|Sana Klinikum Offenbach|Completed|Apr 2016|Jan 2019|Interventional|Apr 2016|Behavior|\nNCT02758652|Tampere University Hospital|Active, not recruiting|May 2016|May 2026|Observational|Apr 2016|Ovarian Neoplasms,Carcinoma|\nNCT02754206|Southern Methodist University|Terminated|Jan 2016|Sep 2021|Observational|Apr 2016|Post-Concussion Syndrome,Brain Concussion|\nNCT02752243|Peter Bader|Active, not recruiting|Mar 2016|Mar 2022|Interventional|Mar 2016|Leukemia,Preleukemia,Myelodysplastic Syndromes,Syndrome,Acute Disease|\nNCT02754856|M.D. Anderson Cancer Center|Active, not recruiting|Jul 2016|Jul 2021|Interventional|Apr 2016|Colorectal Neoplasms|Durvalumab,Ipilimumab,Tremelimumab,Immunoglobulins,Antibodies,Immunoglobulin G\nNCT02759861|University of Nebraska|Active, not recruiting|Aug 2016|Aug 2020|Interventional|Apr 2016|Hepatitis A,Hepatitis C,Hepatitis|Sofosbuvir,Ledipasvir\nNCT02759679|Haukeland University Hospital|Unknown status|May 2016|Dec 2019|Interventional|Mar 2016|Lung Neoplasms|\nNCT02752932|Lawson Health Research Institute|Completed|Nov 2015|Oct 2017|Interventional|Feb 2016|Carcinoma,Squamous Cell Carcinoma of Head and Neck,Neoplasms|\nNCT02759445|RWTH Aachen University|Unknown status|Apr 2016|Oct 2016|Observational|Nov 2015||\nNCT02754622|Guy's and St Thomas' NHS Foundation Trust|Completed|Jul 2016|Dec 2016|Observational|Apr 2016|Critical Illness|\nNCT02756611|AbbVie|Active, not recruiting|Jun 2016|Sep 2022|Interventional|Apr 2016|Leukemia|Venetoclax\nNCT02758223|Wuerzburg University Hospital|Active, not recruiting|Apr 2016|Jun 2021|Interventional|Feb 2016|Leukemia,Myelodysplastic Syndromes|\nNCT02757079|Nobelpharma|Completed|Jun 2016|Jul 2018|Interventional|Apr 2016|Sleep Wake Disorders,Parasomnias,Disease,Neurodevelopmental Disorders|Melatonin\nNCT02754219|Dong-A ST Co., Ltd.|Completed|Sep 2016|Jan 2018|Interventional|Apr 2016|Liver Diseases|\nNCT02753101|Stanford University|Completed|Feb 2016|Feb 2017|Interventional|Apr 2016|Complex Regional Pain Syndromes,Reflex Sympathetic Dystrophy,Sciatica|\nNCT02759003|Fondazione Salvatore Maugeri|Completed|Mar 2011|Mar 2014|Interventional|Apr 2016|Motor Neuron Disease,Amyotrophic Lateral Sclerosis,Sclerosis|\nNCT02752659|University of British Columbia|Completed|Jun 2016|Jun 2017|Interventional|Apr 2016|Breast Neoplasms,Lymphedema|\nNCT02758912|Burnasyan Federal Medical Biophysical Center|Completed|Nov 2016|Oct 2019|Interventional|Apr 2016|Stroke,Angina Pectoris,Infarction,Hemorrhage|\nNCT02754388|National Taiwan University Hospital|Completed|Feb 2016|Dec 2019|Observational [Patient Registry]|Apr 2016|Lung Neoplasms|\nNCT02759666|Atridia Pty Ltd.|Completed|Jun 2016|Apr 2019|Interventional|Apr 2016|Neoplasms|\nNCT02750241|The University of Texas Medical Branch, Galveston|Completed|Apr 2016|Jan 2019|Interventional|Apr 2016|Breast Neoplasms|\nNCT02752568|Kasr El Aini Hospital|Unknown status|May 2016|Dec 2016|Interventional|Apr 2016||\nNCT02758015|University of California, San Francisco|Completed|Jun 2016|Mar 2018|Interventional|Apr 2016||Betaine\nNCT02756884|Arkansas Heart Hospital|Completed|Jun 2015|Jan 2019|Interventional|Apr 2016|Peripheral Arterial Disease,Peripheral Vascular Diseases|\nNCT02758353|JSI Research & Training Institute, Inc.|Completed|Apr 2015|Nov 2015|Interventional|Apr 2016|Malaria,Stillbirth|\nNCT02753751|Yale University|Completed|Mar 2018|Jan 2020|Interventional|Apr 2016|Acute Kidney Injury,Wounds and Injuries|\nNCT02757170|All India Institute of Medical Sciences, New Delhi|Unknown status|Jul 2015|Jul 2016|Interventional|Apr 2016|Liver Failure,Hepatic Insufficiency,End Stage Liver Disease,Acute-On-Chronic Liver Failure|\nNCT02757625|Pfizer|Completed|Jul 2016|May 2017|Interventional|Apr 2016||Dexmedetomidine\nNCT02752347|Riyadh Colleges of Dentistry and Pharmacy|Unknown status|Apr 2016|Dec 2017|Interventional|Apr 2016|Malocclusion|\nNCT02756468|University of Roma La Sapienza|Unknown status|Jan 2015|Dec 2016|Observational [Patient Registry]|Apr 2016|Pancreatic Neoplasms|\nNCT02750410|Eli Lilly and Company|Completed|Aug 2016|\n\n*** WARNING: max output size exceeded, skipping output. ***\n\nst Neoplasms|\nNCT02758990|Verifomics LLC|Terminated|Mar 2016|Nov 2016|Interventional|Apr 2016|Rhinitis,Arthralgia,Dyspnea,Sleep Deprivation,Migraine Disorders,Sleep Initiation and Maintenance Disorders,Disease,Headache,Respiratory Sounds|Vitamin D,Cholecalciferol,Vitamins,Ascorbic Acid,Vitamin E,Tocopherols,Vitamin A,Niacinamide,Niacin,Nicotinic Acids,Pyridoxine,Pyridoxal,Vitamin B 6,Caffeine\nNCT02754193|Central Hospital, Nancy, France|Completed|Oct 2016|Nov 2019|Interventional|Apr 2016|Shock,Hypothermia|\nNCT02758613|Eli Lilly and Company|Completed|May 2016|Jul 2016|Interventional|Apr 2016||\nNCT02751047|Seoul National University Hospital|Completed|May 2016|Jan 2017|Interventional|Apr 2016||\nNCT02758197|Ottawa Hospital Research Institute|Completed|Jul 2016|Oct 2020|Interventional|Apr 2016|Neuralgia,Chronic Pain|\nNCT02753270|University of Sao Paulo|Completed|Dec 2014|Apr 2017|Interventional|Apr 2016|Varicose Veins|\nNCT02750839|Azienda Ospedaliera Bolognini di Seriate Bergamo|Unknown status|Apr 2016|Apr 2016|Observational|Apr 2016|Osteoporosis,Fractures,Humeral Fractures|\nNCT02750488|Bayer|Completed|May 2016|Jul 2016|Interventional|Apr 2016|Dermatitis|\nNCT02752958|GlaxoSmithKline|Completed|May 2016|Feb 2017|Interventional|Apr 2016|Dentin Sensitivity,Hypersensitivity|Fluorides,Tin Fluorides\nNCT02753322|The Queen Elizabeth Hospital|Unknown status|Apr 2016|Mar 2018|Interventional|Apr 2016|Stroke|\nNCT02757261|University of Nove de Julho|Unknown status|Jun 2016|Mar 2017|Interventional|Apr 2016|Bruxism,Sleep Bruxism|Salicylic Acid\nNCT02754427|University of British Columbia|Completed|Feb 2013|Aug 2015|Interventional|Apr 2016|Breast Neoplasms|\nNCT02758366|Meyer Children's Hospital|Terminated|Feb 2016|Jan 2020|Interventional|Apr 2016|Glioblastoma,Glioma,Astrocytoma,Diffuse Intrinsic Pontine Glioma,Neoplasms|Doxorubicin\nNCT02755402|Centre hospitalier de l'Université de Montréal (CHUM)|Completed|Jan 2017|May 2021|Interventional|Apr 2016|Hepatitis C|\nNCT02754453|The Cleveland Clinic|Withdrawn|Jul 2013|Oct 2015|Interventional|Sep 2013|Body Weight,Weight Loss|\nNCT02755103|Medical University of South Carolina|Active, not recruiting|Jun 2016|Oct 2021|Interventional|Apr 2016|Disease,Substance-Related Disorders,Stress Disorders|\nNCT02758834|Università Politecnica delle Marche|Completed|Jan 2014|Apr 2016|Observational|Apr 2016|Liver Diseases|\nNCT02759146|Michigan State University|Completed|May 2016|Nov 2019|Interventional|Apr 2016||\nNCT02754414|Bloodworks|Unknown status|Apr 2016|Jan 2019|Interventional|Apr 2016||\nNCT02759783|Royal Marsden NHS Foundation Trust|Active, not recruiting|Nov 2016|Oct 2024|Interventional|Apr 2016|Carcinoma|\nNCT02756923|Weill Medical College of Cornell University|Suspended|Apr 2012|Dec 2025|Observational|Apr 2016|Infertility|\nNCT02759237|Medtronic Cardiovascular|Terminated|Feb 2016|May 2017|Observational|Apr 2016|Aortic Valve Stenosis|\nNCT02757391|M.D. Anderson Cancer Center|Terminated|Aug 2019|Oct 2020|Interventional|Apr 2016|Carcinoma,Colorectal Neoplasms,Adenocarcinoma,Stomach Neoplasms,Esophageal Neoplasms,Cholangiocarcinoma|Aldesleukin,Cyclophosphamide,Pembrolizumab,Interleukin-2,Immunologic Factors\nNCT02750904|Fred Hutchinson Cancer Research Center|Completed|Apr 2017|May 2019|Interventional|Mar 2016|Disease,Bipolar Disorder|Nicotine\nNCT02758418|Universitat Jaume I|Unknown status|Apr 2016|Jul 2019|Interventional|Apr 2016|Adjustment Disorders|\nNCT02756039|AstraZeneca|Completed|May 2016|Aug 2018|Observational|Apr 2016||\nNCT02755077|Massachusetts General Hospital|Completed|Jul 2014|Jan 2016|Interventional|Apr 2016||\nNCT02751801|Sheffield Teaching Hospitals NHS Foundation Trust|Completed|Nov 2016|Dec 2017|Observational|Apr 2016|Hypophosphatasia|\nNCT02751177|Institut de Cancérologie de Lorraine|Completed|Mar 2016|May 2017|Interventional|Mar 2016|Colorectal Neoplasms|\nNCT02758574|University of Pittsburgh|Completed|May 2016|Aug 2021|Interventional|Mar 2016|Pulmonary Embolism,Embolism|\nNCT02758587|NHS Greater Glasgow and Clyde|Recruiting|Jul 2017|Dec 2021|Interventional|Apr 2016|Mesothelioma,Carcinoma,Pancreatic Neoplasms|Pembrolizumab\nNCT02752100|Third Military Medical University|Unknown status|Mar 2016|May 2020|Interventional|Mar 2016|Arterial Occlusive Diseases|\nNCT02755818|University of California, Davis|Terminated|Oct 2008|Feb 2019|Observational|Mar 2016|Insulin Resistance|Heparin,Calcium heparin\nNCT02752906|Sanofi Pasteur, a Sanofi Company|Completed|Apr 2016|Dec 2016|Interventional|Apr 2016|Meningococcal Infections,Meningitis|Vaccines\nNCT02750371|University Hospital, Bordeaux|Active, not recruiting|Jul 2016|Oct 2021|Interventional|Apr 2016|Adenoma,Meningioma,Pituitary Neoplasms,Pituitary Diseases|\nNCT02751125|University of Bergen|Completed|Jun 2014|Mar 2020|Interventional|Mar 2016|Atrophy|\nNCT02754700|High Point University|Completed|Apr 2016|Feb 2019|Interventional|Apr 2016|Knee Injuries|\nNCT02756442|Assistance Publique Hopitaux De Marseille|Unknown status|Apr 2016|Apr 2019|Interventional|Apr 2016|Respiration Disorders,Respiratory Tract Diseases,Diabetes|\nNCT02756637|Abramson Cancer Center of the University of Pennsylvania|Completed|Apr 2016|Nov 2016|Observational|Apr 2016|Urinary Bladder Neoplasms|\nNCT02755688|Royal Brompton & Harefield NHS Foundation Trust|Unknown status|Jun 2015|Mar 2020|Interventional|Apr 2016|Atrial Fibrillation|\nNCT02753387|Rennes University Hospital|Completed|May 2016|Sep 2018|Interventional|Apr 2016|Bacterial Infections,Head and Neck Neoplasms|Chlorhexidine\nNCT02758470|University of British Columbia|Completed|Nov 2016|Jun 2017|Interventional|Apr 2016|Fatigue,Hypoxia|Acetazolamide,Methazolamide\nNCT02754375|Centre Hospitalier Universitaire de Nice|Unknown status|May 2016|May 2019|Interventional|Apr 2016|Depression,Depressive Disorder|\nNCT02758756|University of Rochester|Completed|Jun 2016|May 2019|Interventional|Apr 2016|Fatigue|\nNCT02750787|Abbott Nutrition|Completed|Aug 2016|Jul 2017|Interventional|Apr 2016|Malabsorption Syndromes|\nNCT02757339|Mclean Hospital|Enrolling by invitation|Jun 2015|May 2022|Observational|Mar 2016|Disease,Stress Disorders,Dissociative Disorders,Dissociative Identity Disorder|\nNCT02753959|Guy's and St Thomas' NHS Foundation Trust|Completed|Aug 2016|Sep 2019|Interventional|Apr 2016|Neuromuscular Diseases|\nNCT02753426|University of California, San Francisco|Completed|Apr 2016|Jan 2018|Interventional|Apr 2016|Kidney Diseases,Renal Insufficiency,Cardio-Renal Syndrome|Doxycycline\nNCT02757183|AnalyticsPlus, Inc.|Unknown status|Apr 2016|Mar 2017|Observational|Apr 2016||\nNCT02750293|University of Tromso|Completed|Jun 2015|Sep 2017|Interventional|Apr 2016|Vitamin D Deficiency|Cholecalciferol\nNCT02757274|European Association of Urology Research Foundation|Recruiting|Feb 2017|Jul 2027|Observational [Patient Registry]|Apr 2016|Urinary Incontinence,Enuresis|\nNCT02756741|All India Institute of Medical Sciences, New Delhi|Completed|Apr 2014|Jul 2015|Interventional|Apr 2016|Peritonitis,Fibrosis|\nNCT02758964|Charite University, Berlin, Germany|Completed|Sep 2016|Jan 2019|Observational|Apr 2016|Intracranial Embolism,Embolism,Aortic Valve Stenosis|\nNCT02753439|The Baruch Padeh Medical Center, Poriya|Unknown status|Feb 2017|Feb 2019|Interventional|Mar 2016|Tooth|\nNCT02751281|Isfahan University of Medical Sciences|Completed|Dec 2014|Apr 2016|Interventional|Apr 2016|Kidney Calculi,Nephrolithiasis|\nNCT02756676|Ospedale Generale Di Zona Moriggia-Pelascini|Completed|Apr 2015|Dec 2016|Interventional|Apr 2016|Parkinson Disease|\nNCT02750215|Massachusetts General Hospital|Completed|May 2016|May 2021|Interventional|Apr 2016|Lung Neoplasms|\nNCT02755935|Cochlear|Completed|May 2016|Sep 2017|Interventional|Apr 2016|Hearing Loss|\nNCT02759523|Penn State University|Completed|Jul 2013|Dec 2015|Observational|Apr 2016|Pediatric Obesity|\nNCT02756533|University Hospital, Grenoble|Recruiting|Aug 2016|Aug 2021|Interventional|Mar 2016|Lung Diseases,Pulmonary Disease,Signs and Symptoms|\nNCT02752841|Brown University|Terminated|May 2016|May 2019|Interventional|Apr 2016|Kidney Calculi,Calculi|Vitamin D\nNCT02758392|Janssen Research & Development, LLC|Completed|Apr 2016|Jan 2017|Interventional|Apr 2016||\nNCT02755870|Clene Nanomedicine|Completed|Apr 2015|Oct 2016|Interventional|Apr 2016||\nNCT02752464|Boston Medical Center|Completed|Sep 2016|Jun 2018|Interventional|Apr 2016||\nNCT02756780|Royal Marsden NHS Foundation Trust|Unknown status|Apr 2016|Apr 2018|Interventional|Apr 2016||\nNCT02753998|Assistance Publique - Hôpitaux de Paris|Active, not recruiting|Dec 2016|Sep 2021|Interventional|Apr 2016|Arteriovenous Fistula,Constriction,Fistula|Paclitaxel\nNCT02751307|Taipei Medical University WanFang Hospital|Completed|May 2013|Jan 2015|Interventional|Apr 2016|Congenital Abnormalities,Metabolic Syndrome,Schizophrenia|Metformin,Clozapine\nNCT02757755|Armata Pharmaceuticals, Inc.|Completed|May 2016|Aug 2016|Interventional|Apr 2016||\nNCT02753972|University of New Mexico|Completed|Aug 2006|Jan 2008|Interventional|Apr 2016||\nNCT02751853|University of Luebeck|Unknown status|Dec 2016|Aug 2020|Interventional|Apr 2016|Heart Failure|\nNCT02752971|Hospital Central Dr. Luis Ortega|Completed|Feb 2015||Interventional|Mar 2016|Pain|Diclofenac,Bupivacaine\nNCT02755012|McGill University|Completed|Jun 2012|Nov 2013|Observational|Apr 2016|Infections,Mastitis,Malnutrition,Infant Nutrition Disorders,Growth Disorders,Stress|\nNCT02751996|F-star Therapeutics, Inc.|Completed|May 2016|Feb 2020|Interventional|Apr 2016|Hepatitis A,Hepatitis B,Hepatitis|Tenofovir\nNCT02752893|Dartmouth-Hitchcock Medical Center|Completed|Jan 2017|Apr 2019|Observational|Apr 2016|Breast Neoplasms|\nNCT02753842|Global Protection Corp.|Completed|May 2016|Jul 2017|Interventional|Apr 2016||\nNCT02757040|Peking University People's Hospital|Unknown status|Dec 2016|Dec 2018|Interventional|Apr 2016|Leukemia|Arsenic Trioxide\nNCT02751606|Radboud University|Unknown status|Jun 2015|Nov 2019|Interventional|Nov 2014|Neoplasms,Breast Neoplasms,Rectal Neoplasms|\nNCT02751372|Bayer|Completed|May 2016|May 2016|Interventional|Apr 2016||\nNCT02753764|National Jewish Health|Completed|Jan 2017|Feb 2019|Interventional|Apr 2016|Asthma|Prednisone,AZD7624\nNCT02758938|University of Wisconsin, Madison|Completed|Jun 2016|Sep 2018|Interventional|Dec 2015|Lower Urinary Tract Symptoms|\nNCT02752399|Federal University of São Paulo|Unknown status|Apr 2016|Jun 2017|Observational|Apr 2016|Hypertension,Heart Defects,Eisenmenger Complex|\nNCT02753296|University of Sheffield|Unknown status|May 2016|Jun 2018|Observational|Apr 2016||\nNCT02759432|Teesside University|Completed|May 2016|Jul 2016|Interventional|Apr 2016||\nNCT02750137|KK Women's and Children's Hospital|Completed|Aug 2014|May 2015|Observational|Apr 2016|Drug-Related Side Effects and Adverse Reactions|Tetracaine\nNCT02754466|University of Brasilia|Terminated|May 2017|Sep 2021|Interventional|Apr 2016|Dental Caries|\nNCT02752191|Paul Finn|Recruiting|Apr 2016|Apr 2021|Interventional|Apr 2016|Heart Diseases,Heart Defects|Ferrosoferric Oxide\nNCT02753517|University Hospital, Lille|Recruiting|Dec 2015|Nov 2023|Interventional|Apr 2016|Liver Failure,Hepatic Insufficiency|\nNCT02758054|University of Texas Southwestern Medical Center|Active, not recruiting|Jun 2017|Mar 2023|Interventional|Apr 2016|Carcinoma|\nNCT02757573|Tampere University Hospital|Active, not recruiting|Apr 2016|Dec 2022|Interventional|Apr 2016|Hypercapnia|\nNCT02752789|National Institute of Allergy and Infectious Diseases (NIAID)|Completed|Jul 2014|Nov 2019|Observational|Apr 2016||\nNCT02756416|University of Nottingham|Unknown status|Jul 2016|May 2017|Interventional|Mar 2016|Syndrome|\nNCT02758106|Chung Shan Medical University|Completed|Feb 2014|Nov 2015|Interventional|Apr 2016|Respiratory Insufficiency|\nNCT02759159|Xuanwu Hospital, Beijing|Unknown status|Jun 2016|Dec 2018|Interventional|Apr 2016|Alzheimer Disease|\nNCT02753777|University of Pennsylvania|Recruiting|Apr 2016|Dec 2025|Observational [Patient Registry]|Apr 2016|Pemphigoid,Pemphigus|\nNCT02754245|Baylor Research Institute|Unknown status|Nov 2016|Jul 2017|Observational|Apr 2016|Emergencies|\nNCT02754687|Health Decisions|Unknown status|Apr 2016|Jan 2020|Interventional|Mar 2016||Nandrolone Decanoate,Nandrolone,Nandrolone phenpropionate\nNCT02755337|Dr. Soetomo General Hospital|Unknown status|Jan 2016|Dec 2016|Observational|Apr 2016|Lung Neoplasms|\nNCT02755090|University of New Mexico|Completed|Jul 2016|May 2017|Interventional|Apr 2016||Nitrous Oxide\nNCT02751437|Liverpool Women's NHS Foundation Trust|Completed|Aug 2016|Mar 2018|Interventional|Mar 2016|Premature Birth|\nNCT02757950|GlaxoSmithKline|Completed|Jul 2016|May 2017|Observational|Apr 2016|Diphtheria|\nNCT02756754|University Hospital, Toulouse|Completed|Nov 2016|May 2019|Interventional|Apr 2016|Adenoma,Adrenocortical Adenoma,Hyperaldosteronism|\nNCT02754726|HonorHealth Research Institute|Active, not recruiting|Apr 2016|Jun 2022|Interventional|Apr 2016|Adenocarcinoma|Gemcitabine,Paclitaxel,Nivolumab,Albumin-Bound Paclitaxel\nNCT02759549|Emory University|Withdrawn|Sep 2015||Interventional|Apr 2016|Breast Neoplasms|\nNCT02755714|Haukeland University Hospital|Completed|Jun 2016|Oct 2020|Interventional|Apr 2016||Bromides,Ipratropium\nNCT02750358|Memorial Sloan Kettering Cancer Center|Active, not recruiting|May 2016|May 2022|Interventional|Apr 2016|Breast Neoplasms,Triple Negative Breast Neoplasms|\nNCT02754921|Mohamed Sayed Mohamed Abbas|Completed|Jan 2013||Interventional|Apr 2016||\nNCT02755259|University of Zurich|Completed|Jan 2017|Apr 2019|Interventional|Mar 2016|Hypertension|Acetazolamide\nNCT02759081|Dalin Tzu Chi General Hospital|Completed|Jan 2015||Interventional|Apr 2016||\nNCT02755155|University Hospital, Strasbourg, France|Terminated|Sep 2016|Aug 2019|Interventional|Apr 2016|Hypoalbuminemia,Syndrome,Systemic Inflammatory Response Syndrome|\nNCT02758119|Ilumens|Completed|Jun 2016|Oct 2016|Interventional|Apr 2016|Heart Arrest,Out-of-Hospital Cardiac Arrest|\nNCT02755415|China Medical University Hospital|Unknown status|May 2016|Dec 2017|Interventional|Apr 2016|Stroke|\nNCT02751268|Armed Forces Hampyeong Hospital|Unknown status|Apr 2016|Mar 2017|Interventional|Apr 2016|Psychomotor Agitation,Emergence Delirium|Ropivacaine\nNCT02756572|University of Washington|Completed|Sep 2016|Jul 2020|Interventional|Apr 2016|Leukemia,Neoplasms,Preleukemia,Myelodysplastic Syndromes,Anemia,Syndrome|Cytarabine,Cyclosporine,Mycophenolic Acid,Sirolimus,Fludarabine,Fludarabine phosphate,Melphalan,Mechlorethamine,Mitoxantrone,Nitrogen Mustard Compounds,Cladribine,2-chloro-3-deoxyadenosine,Cyclosporins,Lenograstim\nNCT02756871|Institute of Child Health|Completed|Jul 2015|Feb 2017|Interventional|Apr 2016||\nNCT02750618|Ultragenyx Pharmaceutical Inc|Completed|May 2016|Sep 2019|Interventional|Dec 2015|Familial Hypophosphatemic Rickets,Hypophosphatemia|\nNCT02757196|Peking University People's Hospital|Unknown status|May 2016|Dec 2018|Interventional|Apr 2016|Thrombocytopenia,Purpura|Methylprednisolone,Methylprednisolone Acetate,Methylprednisolone Hemisuccinate,Prednisolone,Prednisolone acetate,Rituximab,Prednisolone hemisuccinate,Prednisolone phosphate\nNCT02758093|University of Alabama at Birmingham|Completed|Sep 2016|Mar 2020|Interventional|Mar 2016||\nNCT02750943|GlaxoSmithKline|Completed|Nov 2015|Mar 2016|Interventional|Nov 2015|Gingivitis|Fluorides,Tin Fluorides,Fluorophosphate\nNCT02754908|The University of Hong Kong|Completed|Jan 2016|Jun 2018|Interventional|Apr 2016|Brain Neoplasms|\nNCT02750514|Bristol-Myers Squibb|Terminated|May 2016|Jan 2020|Interventional|Apr 2016|Carcinoma|Nivolumab,Ipilimumab,Dasatinib,Linrodostat\nNCT02755350|LVCT Health|Unknown status|Aug 2015|Apr 2017|Interventional|Nov 2015||Emtricitabine\nNCT02753374|Beijing Children's Hospital|Not yet recruiting|May 2016|Jul 2030|Observational|Apr 2016|Cystic Fibrosis,Fibrosis|\nNCT02759419|Bayer|Recruiting|Jun 2016|Dec 2023|Interventional|Apr 2016|Pulmonary Arterial Hypertension,Hypertension|Riociguat\nNCT02757612|Universidad de Murcia|Completed|Jun 2015|Jul 2016|Interventional|Apr 2016|Burning Mouth Syndrome,Syndrome,Burns|\nNCT02754297|CHU de Quebec-Universite Laval|Recruiting|Apr 2016|Dec 2026|Interventional|Mar 2016|Neoplasms,Neuroendocrine Tumors,Carcinoid Tumor,Carcinoma|Lutetium Lu 177 dotatate\nNCT02758665|University of Ulm|Active, not recruiting|Sep 2016|Mar 2022|Interventional|Apr 2016|Leukemia|Venetoclax,Obinutuzumab\nNCT02755285|Fujifilm Medical Systems USA, Inc.|Completed|Aug 2016|Oct 2016|Interventional|Apr 2016||\nNCT02757690|Asan Medical Center|Completed|Jan 2015|Feb 2016|Interventional|Apr 2016|Neoplasms,Brain Neoplasms|\nNCT02753218|LEO Pharma|Terminated|Apr 2016|May 2016|Interventional|Apr 2016|Psoriasis|Midazolam\nNCT02754986|University of Hyogo|Completed|Mar 2015||Interventional|Mar 2016|Kidney Diseases,Renal Insufficiency|\nNCT02752048|Taiho Pharmaceutical Co., Ltd.|Completed|May 2016|Oct 2017|Interventional|Apr 2016|Muscular Dystrophies,Muscular Dystrophy|\nNCT02752256|University of Iowa|Completed|Oct 2015|Oct 2017|Observational|Apr 2016||Plasminogen,Tissue Plasminogen Activator\nNCT02756936|Genuine Research Center, Egypt|Completed|Feb 2016|Mar 2016|Interventional|Apr 2016||\nNCT02756000|Clinical Hospital Center Zemun|Unknown status|Jan 2016|Jul 2018|Interventional|Apr 2016|Coronary Artery Disease,Myocardial Ischemia,Coronary Disease,Myocardial Infarction,Infarction|Dobutamine\nNCT02754492|Terumo BCT|Completed|Apr 2016|Feb 2017|Interventional|Apr 2016||\nNCT02757677|Swiss Vision Network|Unknown status|Dec 2015|Dec 2019|Observational|Apr 2016|Glaucoma|\nNCT02752373|Brain Sentinel|Terminated|May 2016|Feb 2017|Observational|Mar 2016|Epilepsy,Seizures|\nNCT02752230|Kettering Health Network|Withdrawn|Nov 2016|Jun 2021|Interventional|Mar 2016|Pain|\nNCT02756728|BioInvent International AB|Terminated|May 2016|Dec 2016|Interventional|Apr 2016|Multiple Myeloma,Neoplasms|Melphalan\nNCT02751658|University Hospital, Montpellier|Completed|Nov 2016|Jul 2019|Interventional|Mar 2016|Otorhinolaryngologic Diseases|\nNCT02754518|University of Chicago|Completed|Apr 2016|Apr 2019|Interventional|Apr 2016|Heart Failure|Valsartan,Sacubitril and valsartan sodium hydrate drug combination\nNCT02759380|Sahlgrenska University Hospital, Sweden|Recruiting|Mar 2016|Oct 2022|Interventional|Apr 2016|Prostatic Neoplasms|Phytoestrogens\nNCT02755649|Regeneron Pharmaceuticals|Completed|Jan 2016|Mar 2017|Interventional|Mar 2016|Dermatitis,Eczema|\nNCT02751827|Institut Bergonié|Completed|Feb 2016|Nov 2019|Observational|Apr 2016||\nNCT02755545|Galderma Laboratories, L.P.|Completed|May 2016|Apr 2017|Interventional|Apr 2016|Acne Vulgaris|Salicylic Acid,Adapalene,Salicylates\nNCT02750345|Cycle Pharmaceuticals Ltd.|Completed|Mar 2016|May 2016|Interventional|Apr 2016|Tyrosinemias|Nitisinone\nNCT02755532|Federal University of São Paulo|Completed|Jan 2014|Oct 2015|Interventional|Apr 2016||Bupivacaine\nNCT02758743|Biohit Oyj|Completed|Apr 2016|May 2017|Interventional|Apr 2016||\nNCT02754947|Nationwide Children's Hospital|Completed|Feb 2015|Mar 2016|Observational|Apr 2016|Respiration Disorders,Respiratory Tract Diseases,Nervous System Diseases,Cardiovascular Diseases|\nNCT02750280|Calvary Hospital, Bronx, NY|Completed|Jun 2015|Dec 2015|Interventional|Apr 2016|Diabetic Foot,Foot Ulcer,Ulcer|\nNCT02756325|NYU Langone Health|Withdrawn|Jun 2016|Jan 2019|Interventional|Apr 2016|Infertility|\nNCT02758717|Academic and Community Cancer Research United|Active, not recruiting|May 2016|May 2024|Interventional|Apr 2016|Lymphoma,Hodgkin Disease|Antineoplastic Agents,Nivolumab,Brentuximab Vedotin,Antibodies,Immunoglobulins,Immunoconjugates\nNCT02751034|Medy-Tox|Completed|Jun 2013|Jan 2014|Interventional|Apr 2015||Lidocaine\nNCT02751476|Action Contre la Faim|Unknown status|Apr 2016|Mar 2017|Interventional|Apr 2016|Malnutrition,Severe Acute Malnutrition,Protein-Energy Malnutrition|Disinfectants\nNCT02755454|University Health Network, Toronto|Completed|Oct 2013|Nov 2018|Interventional|Mar 2016|Lung Neoplasms|\nNCT02752867|Dongfang Hospital Beijing University of Chinese Medicine|Unknown status|Dec 2016|Nov 2019|Interventional|Mar 2016|Cerebral Infarction,Infarction,Cognitive Dysfunction|\nNCT02754830|Eli Lilly and Company|Completed|Apr 2016|Jul 2018|Interventional|Apr 2016|Alzheimer Disease|\nNCT02753738|Medical University of Vienna|Unknown status|Aug 2016||Interventional|Apr 2016||Citalopram\nNCT02750267|University of Virginia|Completed|May 2016|May 2016|Interventional|Apr 2016|Diabetes Mellitus|\nNCT02754999|Prolong Pharmaceuticals|Completed|Mar 2016|May 2017|Interventional|Apr 2016|Anemia|\nNCT02754843|Sonova AG|Completed|Oct 2015||Interventional|Oct 2015|Hearing Loss|\nNCT02759055|HealthPartners Institute|Completed|Oct 2016|Dec 2019|Interventional|Apr 2016|Prediabetic State,Glucose Intolerance|\nNCT02753673|Memorial Sloan Kettering Cancer Center|Completed|Apr 2016|Apr 2020|Observational|Apr 2016||\nNCT02754531|Indonesia University|Completed|May 2016|Jul 2016|Interventional|Apr 2016||\nNCT02750033|Seton Healthcare Family|Withdrawn|Oct 2016|Mar 2017|Observational|Apr 2016|Carcinoma|\nNCT02759133|Centre Antoine Lacassagne|Recruiting|Jun 2016|Nov 2022|Interventional|Apr 2016|Breast Neoplasms|\nNCT02756650|Novartis Pharmaceuticals|Completed|Jun 2016|Jan 2019|Interventional|Mar 2016|Behcet Syndrome|\nNCT02752152|Institut de Recherche pour le Developpement|Completed|Dec 2015|Oct 2020|Interventional|Apr 2016|Hepatitis A,Hepatitis C,Hepatitis B,Syphilis,Hepatitis|\nNCT02751385|Boehringer Ingelheim|Terminated|May 2016|Nov 2017|Interventional|Apr 2016|Carcinoma|Nintedanib,Ethinyl estradiol,Ethinyl Estradiol-Norgestrel Combination\nNCT02751879|Boehringer Ingelheim|Completed|Nov 2016|Sep 2017|Observational|Apr 2016|Carcinoma|\nNCT02756663|Novartis Pharmaceuticals|Withdrawn|Dec 2016|Feb 2021|Interventional|Apr 2016|Multiple Myeloma,Neoplasms|Dexamethasone,Panobinostat\nNCT02756273|Centre Hospitalier Universitaire, Amiens|Recruiting|May 2016|May 2022|Interventional|Apr 2016||\nNCT02755974|Imperial College London|Unknown status|Jan 2009|Apr 2021|Observational|Apr 2016|Lung Diseases,Pulmonary Disease|\nNCT02756507|Babes-Bolyai University|Completed|Jun 2016|Jun 2018|Interventional|Apr 2016|Disease,Depression,Anxiety Disorders,Panic Disorder|\nNCT02750553|Jiangsu HengRui Medicine Co., Ltd.|Completed|Jan 2015||Interventional|Apr 2016||\nNCT02750228|Mednax Center for Research, Education, Quality and Safety|Completed|May 2016|Jun 2020|Observational|Mar 2016|Ductus Arteriosus|\nNCT02751710|Ontario Clinical Oncology Group (OCOG)|Recruiting|Dec 2016|Dec 2022|Interventional|Apr 2016|Breast Neoplasms|\nNCT02753361|Suez Canal University|Completed|May 2016|Dec 2016|Interventional|Apr 2016|Lipoma|\nNCT02753634|Lawson Health Research Institute|Completed|Apr 2015|Jun 2016|Interventional|Mar 2016|Osteoarthritis|\nNCT02759250|argenx|Completed|Feb 2015|Jun 2018|Interventional|Apr 2016|Nasopharyngeal Carcinoma|\nNCT02757482|Celal Bayar University|Completed|Sep 2014|Jun 2015|Interventional|Apr 2016||\nNCT02757105|RedHill Biopharma Limited|Completed|May 2016|Jul 2017|Interventional|Apr 2016|Irritable Bowel Syndrome,Syndrome,Diarrhea|Ondansetron\nNCT02756520|Fresenius Kabi|Completed|Sep 2016|Oct 2018|Observational|Apr 2016|Kidney Diseases,Renal Insufficiency|\nNCT02753309|The University of Texas Health Science Center at San Antonio|Completed|Jun 2016|Mar 2021|Interventional|Apr 2016|Urinary Bladder Neoplasms|Sirolimus\nNCT02756832|Takeda|Completed|Sep 2016|Apr 2018|Observational|Apr 2016|Diabetes Mellitus|Alogliptin\nNCT02758158|University Health Network, Toronto|Completed|Jan 2016|Feb 2017|Interventional|Mar 2016|Thyroid Neoplasms,Thyroid Nodule,Thyroid Diseases|\nNCT02752360|Beijing Friendship Hospital|Unknown status|Apr 2016|Dec 2018|Interventional|Apr 2016|Colonic Neoplasms,Crohn Disease,Diverticulum,Diverticular Diseases,Diverticulosis|\nNCT02757794|Assistance Publique Hopitaux De Marseille|Recruiting|Nov 2016|Jun 2022|Interventional|Apr 2016|Memory Disorders|\nNCT02751346|Washington University School of Medicine|Completed|Jan 2016|Feb 2017|Observational|Apr 2016|Pain|\nNCT02757027|Konkuk University Medical Center|Unknown status|May 2016|Jan 2017|Interventional|Apr 2016||\nNCT02756689|University of Alabama at Birmingham|Completed|Mar 2016|Oct 2017|Interventional|Apr 2016||\nNCT02751164|Intensive Care National Audit & Research Centre|Completed|Apr 2013|May 2016|Observational|Apr 2016|Critical Illness|\nNCT02754765|Médecins Sans Frontières, France|Recruiting|Dec 2016|Aug 2023|Interventional|Apr 2016|Tuberculosis,Bacterial Infections|Moxifloxacin,Levofloxacin,Ofloxacin,Linezolid,Pyrazinamide,Bedaquiline,Clofazimine\nNCT02757729|Amorepacific Corporation|Completed|Oct 2015||Interventional|Apr 2016|Dermatitis,Eczema|\nNCT02751866|University of Cincinnati|Recruiting|Jan 2016|Jul 2023|Interventional|Apr 2016|Overweight,Hyperphagia|\nNCT02759068|Hospices Civils de Lyon|Completed|Nov 2014|May 2017|Interventional|Apr 2016|Consciousness Disorders|\nNCT02752503|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|Un\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["[Truncated to first 65536 bytes]\nId|Sponsor|Status|Start|Completion|Type|Submission|Conditions|Interventions\nNCT02758028|The University of Hong Kong|Recruiting|Aug 2005|Nov 2021|Interventional|Apr 2016||\nNCT02751957|Duke University|Completed|Jul 2016|Jul 2020|Interventional|Apr 2016|Autistic Disorder,Autism Spectrum Disorder|\nNCT02758483|Universidade Federal do Rio de Janeiro|Completed|Mar 2017|Jan 2018|Interventional|Apr 2016|Diabetes Mellitus|\nNCT02759848|Istanbul Medeniyet University|Completed|Jan 2012|Dec 2014|Observational|May 2016|Tuberculosis,Lung Diseases,Pulmonary Disease|\nNCT02758860|University of Roma La Sapienza|Active, not recruiting|Jun 2016|Sep 2020|Observational [Patient Registry]|Apr 2016|Diverticular Diseases,Diverticulum,Diverticulosis|\nNCT02757209|Consorzio Futuro in Ricerca|Completed|Apr 2016|Jan 2018|Interventional|Apr 2016|Asthma|Fluticasone,Xhance,Budesonide,Formoterol Fumarate,Salmeterol Xinafoate\nNCT02752438|Ankara University|Unknown status|May 2016|Jul 2017|Observational [Patient Registry]|Apr 2016|Hypoventilation|\nNCT02753543|Ruijin Hospital|Unknown status|Nov 2015|Nov 2019|Interventional|Apr 2016|Lymphoma|\nNCT02757508|Washington University School of Medicine|Completed|Mar 2016|Jul 2017|Interventional|Apr 2016||Vitamins\nNCT02753530|Orphazyme|Completed|Aug 2017|Jan 2021|Interventional|Apr 2016|Myositis|\nNCT02754817|Novo Nordisk A/S|Completed|Apr 2016|Oct 2016|Observational|Apr 2016|Diabetes Mellitus|Liraglutide,Xultophy\nNCT02759276|Daniel Alexandre Bottino|Completed|May 2015|Dec 2015|Observational|Apr 2016|Hypertension|\nNCT02750956|Bulent Ecevit University|Completed|Jun 2015|Mar 2016|Observational|Apr 2016|Periodontal Diseases|\nNCT02752113|Institut für Pharmakologie und Präventive Medizin|Completed|Apr 2016|May 2019|Interventional|Apr 2016|Diabetes Mellitus|Metformin,Empagliflozin,Linagliptin\nNCT02752698|The Third Xiangya Hospital of Central South University|Active, not recruiting|Jan 2015|Dec 2021|Interventional|Jun 2015|Appendicitis,Stomach Ulcer,Cholecystolithiasis,Cholelithiasis,Gallstones|\nNCT02755779|Tel Aviv Medical Center|Unknown status|Jun 2016|Jun 2017|Observational|Apr 2016||\nNCT02750384|Medicines for Malaria Venture|Terminated|May 2016|Jul 2016|Interventional|Apr 2016||\nNCT02754609|James Cook University, Queensland, Australia|Completed|Sep 2016|Oct 2019|Interventional|Apr 2016|Hookworm Infections,Celiac Disease|\nNCT02755701|Soonchunhyang University Hospital|Unknown status|Jul 2016|Dec 2018|Interventional|Apr 2016|Ascites|\nNCT02751762|Member Companies of the Opioid PMR Consortium|Recruiting|Nov 2017|Oct 2022|Observational|Apr 2016|Chronic Pain,Substance-Related Disorders,Opioid-Related Disorders,Narcotic-Related Disorders,Behavior|\nNCT02756299|Marmara University|Completed|Jun 2014|Apr 2015|Interventional|Apr 2016|Sleep Apnea Syndromes,Sleep Apnea|\nNCT02750709|Cycle Pharmaceuticals Ltd.|Completed|Oct 2015|Jan 2016|Interventional|Apr 2016|Tyrosinemias|Nitisinone\nNCT02753907|Yonsei University|Completed|Jun 2015||Interventional|Apr 2016||\nNCT02755467|Cutera Inc.|Completed|May 2016|Apr 2017|Interventional|Apr 2016|Hemangioma|\nNCT02755298|University of Zurich|Completed|Oct 2016|Nov 2020|Interventional|Mar 2016|Hypertension|Acetazolamide\nNCT02759614|Guangdong Association of Clinical Trials|Unknown status|Apr 2016|Jun 2019|Interventional|Mar 2016|Carcinoma|Bevacizumab,Erlotinib Hydrochloride\nNCT02752815|Ruijin Hospital|Unknown status|Apr 2016|Jun 2020|Interventional|Apr 2016|Lymphoma|Prednisone,Cyclophosphamide,Rituximab,Vincristine,Epirubicin\nNCT02757131|The Cleveland Clinic|Completed|Jul 2016|Jul 2017|Interventional|Apr 2016|Iatrogenic Disease|\nNCT02758704|St. Justine's Hospital|Completed|Oct 2015|Jun 2021|Interventional|Apr 2016||\nNCT02750501|Alcresta Therapeutics, Inc.|Completed|Jul 2016|Mar 2017|Interventional|Apr 2016|Cystic Fibrosis,Fibrosis|\nNCT02759913|Iron Horse Diagnostics, Inc.|Unknown status|Jan 2015|Dec 2016|Observational|Apr 2016|Motor Neuron Disease,Amyotrophic Lateral Sclerosis,Sclerosis|\nNCT02752724|VA Puget Sound Health Care System|Completed|Mar 2016|Apr 2018|Interventional|Mar 2016|Depressive Disorder,Depression|Ketamine,Methohexital\nNCT02758444|University of Colorado, Denver|Completed|Nov 2015|Feb 2019|Interventional|Apr 2016||Micronutrients,Trace Elements\nNCT02758067|H. Lundbeck A/S|Withdrawn|Jun 2016||Interventional|Apr 2016|Schizophrenia|Risperidone,Brexpiprazole\nNCT02759341|Ospedale San Giovanni Bellinzona|Completed|Feb 2016|Nov 2017|Interventional|Apr 2016|Myocardial Infarction,Cardiomyopathies,Microvascular Angina,Takotsubo Cardiomyopathy,Syndrome,Infarction|\nNCT02753803|Dong-A ST Co., Ltd.|Completed|Jul 2016|Mar 2017|Interventional|Apr 2016||Pioglitazone\nNCT02752490|The University of Texas Health Science Center, Houston|Completed|Apr 2016|Jul 2016|Interventional|Apr 2016||\nNCT02759562|Gilead Sciences|Terminated|Nov 2016|Jul 2017|Interventional|Apr 2016|Cystic Fibrosis,Fibrosis|\nNCT02758262|Laval University|Unknown status|Apr 2016|Dec 2017|Interventional|Apr 2016|Hyperphagia|\nNCT02754258|Children's Hospital of Eastern Ontario|Unknown status|Jan 2017|Dec 2018|Interventional|Apr 2016||Methylphenidate\nNCT02755207|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|Unknown status|Apr 2016|Dec 2020|Observational|Mar 2016|Acute Coronary Syndrome,Syndrome|\nNCT02759900|The Skin Center Dermatology Group|Recruiting|Jan 2016|Jan 2023|Interventional|Apr 2016|Molluscum Contagiosum,Keratosis,Bowens Disease,Rosacea,Skin Diseases|\nNCT02752581|Mert Özcan|Completed|Jan 2009|Apr 2013|Interventional|Apr 2016|Hemarthrosis|\nNCT02759796|Instituto de Investigación Hospital Universitario La Paz|Completed|Nov 2015|Apr 2017|Interventional|Apr 2016|Necrosis,Neovascularization,Fat Necrosis|\nNCT02754063|University Hospital, Grenoble|Active, not recruiting|Jun 2016|Apr 2022|Interventional|Apr 2016|Brain Injuries,Wounds and Injuries|3\nNCT02750917|Foisor Orthopedics Clinical Hospital|Completed|Sep 2014|Mar 2015|Interventional|Feb 2016|Pain|Etoricoxib,Lornoxicam\nNCT02753569|Institute of Cancer Research, United Kingdom|Completed|May 2016|May 2020|Observational|Apr 2016||\nNCT02751255|VU University Medical Center|Active, not recruiting|Jul 2016|Mar 2022|Interventional|Apr 2016|Multiple Myeloma,Neoplasms|Tretinoin\nNCT02751528|NantBioScience, Inc.|Unknown status|Dec 2016|Dec 2020|Interventional|Apr 2016|Breast Neoplasms|Vaccines\nNCT02751619|University of Campania Luigi Vanvitelli|Completed|Jan 2013|Dec 2015|Interventional|Apr 2016|Pain|Lidocaine\nNCT02757833|Lawson Health Research Institute|Withdrawn|Feb 2019|Feb 2019|Interventional|Apr 2016|Depression,Depressive Disorder|\nNCT02750761|Merck Sharp & Dohme Corp.|Completed|May 2016|Dec 2018|Interventional|Apr 2016|Infections,Bacterial Infections,Gram-Positive Bacterial Infections|Tedizolid phosphate,Tedizolid,Oxazolidinones\nNCT02752594|Sharda University|Completed|Apr 2015|Apr 2015|Interventional|Apr 2016|Dental Caries|\nNCT02753452|Holland Bloorview Kids Rehabilitation Hospital|Unknown status|May 2015|Mar 2020|Interventional|Apr 2016||\nNCT02752763|Niğde State Hospital|Completed|Oct 2015|Mar 2016|Interventional|Mar 2016|Dry Eye Syndromes,Keratoconjunctivitis Sicca|Dextrans,Povidone,Ophthalmic Solutions,Lubricant Eye Drops\nNCT02753816|Spectrum Health Hospitals|Terminated|Apr 2016|Dec 2019|Interventional|Apr 2016|Burns|Tranexamic Acid\nNCT02751294|GlaxoSmithKline|Completed|May 2016|Aug 2016|Interventional|Apr 2016|Malaria|Tafenoquine\nNCT02756429|Hospices Civils de Lyon|Completed|Feb 2014|Jan 2018|Interventional|Apr 2016|Atrial Fibrillation|\nNCT02750163|Università Politecnica delle Marche|Completed|Jul 2017|Jun 2019|Observational|Apr 2016|Shock|Acetaminophen\nNCT02751905|Biogen|Completed|Apr 2016|May 2016|Interventional|Apr 2016|Neuralgia|\nNCT02753153|University of Liege|Completed|May 2011|May 2015|Interventional|Apr 2016|Tooth Loss|\nNCT02750891|Sumitomo Dainippon Pharma Co., Ltd.|Completed|Apr 2016|Jan 2020|Interventional|Apr 2016|Glioblastoma,Glioma,Diffuse Intrinsic Pontine Glioma|\nNCT02751073|Mayo Clinic|Completed|Feb 2016|Jul 2018|Observational|Feb 2016|Infections,Communicable Diseases,Urinary Tract Infections,Prolapse,Pelvic Organ Prolapse|\nNCT02753114|University of British Columbia|Completed|Nov 2017|May 2018|Interventional|Apr 2016|Acute Pain|Ketamine\nNCT02752516|Chia Tai Tianqing Pharmaceutical Group Co., Ltd.|Unknown status|Apr 2016|Dec 2017|Interventional|Apr 2016||\nNCT02752269|Medical University of Graz|Completed|Oct 2014|Jun 2019|Observational|Nov 2015|Sjogrens Syndrome,Hypertension,Vascular Diseases,Syndrome|\nNCT02754713|Hippocration General Hospital|Recruiting|Sep 2009|Dec 2025|Observational|Apr 2016|Pericarditis|\nNCT02759770|Beijing Anzhen Hospital|Completed|Jul 2017|Sep 2017|Observational|Apr 2016|Respiratory Distress Syndrome,Acute Lung Injury|\nNCT02755129|Medtronic BRC|Completed|Sep 2016|Jul 2017|Interventional|Mar 2016|Frailty|\nNCT02754674|Samsung Medical Center|Completed|May 2014|Dec 2017|Interventional|Feb 2015|Rupture|\nNCT02757521|Washington University School of Medicine|Terminated|Mar 2016|Dec 2016|Interventional|Apr 2016|Disease,Depression,Depressive Disorder,Bipolar Disorder|Nitrous Oxide\nNCT02750774|University of Modena and Reggio Emilia|Unknown status|Dec 2015|Dec 2016|Interventional|Apr 2016|Diabetes,Obesity,Pregnancy Complications,Fetal Macrosomia,Overweight,Birth Weight|\nNCT02754739|Samsung Medical Center|Completed|Apr 2014|Aug 2017|Interventional|Apr 2016|Diabetes Mellitus,Prediabetic State|Pravastatin\nNCT02758808|University of Michigan|Recruiting|Mar 2016|Oct 2023|Observational [Patient Registry]|Apr 2016|Lung Diseases,Pulmonary Fibrosis,Idiopathic Pulmonary Fibrosis,Fibrosis|\nNCT02751840|Tel Hai College|Completed|Oct 2014|Apr 2016|Interventional|Apr 2016|Asymptomatic Diseases|Caffeine\nNCT02752451|University of Arizona|Completed|Mar 2015|Apr 2015|Interventional|Apr 2016||\nNCT02757599|Rigshospitalet, Denmark|Completed|Aug 2016|Jun 2017|Interventional|Apr 2016||\nNCT02753894|Astellas Pharma Inc|Completed|Jan 2008|Jun 2008|Interventional|Mar 2016|Kidney Diseases,Renal Insufficiency,Hyperphosphatemia|\nNCT02757638|Texas A&M University|Active, not recruiting|Oct 2015|Oct 2021|Interventional|Feb 2016|Weight Loss|\nNCT02757378|Kevin Farrell|Completed|May 2015|Sep 2015|Interventional|Apr 2016|Back Pain,Low Back Pain|\nNCT02751489|Bayer|Completed|May 2016|May 2016|Interventional|Apr 2016|Dermatitis|\nNCT02759315|Merck Sharp & Dohme Corp.|Terminated|May 2016|Nov 2017|Interventional|Apr 2016|Hepatitis A,Hepatitis C,Hepatitis|Uprifosbuvir,Ruzasvir\nNCT02754895|Massachusetts General Hospital|Completed|Oct 2014|May 2017|Interventional|Apr 2016|Acute Coronary Syndrome,Syndrome|\nNCT02750475|Bayer|Completed|May 2016|May 2016|Interventional|Apr 2016|Dermatitis|Sunscreening Agents\nNCT02755064|Adil Bharucha|Completed|Jun 2010|Nov 2013|Interventional|Apr 2016|Diabetes Mellitus|Erythromycin,Erythromycin Estolate,Erythromycin Ethylsuccinate,Erythromycin stearate,Erythromycin lactobionate\nNCT02758002|University of California, San Diego|Withdrawn|Jan 2016|Dec 2018|Interventional|Apr 2016|Atrial Fibrillation|\nNCT02755142|medac GmbH|Completed|Feb 2000|Jun 2001|Interventional|Apr 2016|Glioma,Brain Neoplasms|Aminolevulinic Acid\nNCT02756364|Millennium Pharmaceuticals, Inc.|Completed|Jul 2016|Nov 2019|Interventional|Apr 2016|Breast Neoplasms|Fulvestrant\nNCT02759484|Rush University Medical Center|Unknown status|Mar 2015|Mar 2019|Interventional|Dec 2015|Hypertension,Diabetes Mellitus,Hyperglycemia|\nNCT02752061|Harvard School of Public Health (HSPH)|Completed|May 2016|Jul 2020|Interventional|Apr 2016||\nNCT02756598|Aarhus University Hospital|Completed|Jan 2015|Jun 2018|Interventional|Dec 2015||Sufentanil,Dsuvia,Propofol\nNCT02755727|Royal Devon and Exeter NHS Foundation Trust|Completed|Mar 2016|Sep 2017|Interventional|Apr 2016|Tennis Elbow|\nNCT02754882|Samsung Bioepis Co., Ltd.|Completed|Jul 2016|Oct 2018|Interventional|Mar 2016|Lung Neoplasms,Carcinoma|Paclitaxel,Bevacizumab,Carboplatin\nNCT02754778|Martin-Luther-Universität Halle-Wittenberg|Completed|Apr 2016|Mar 2021|Interventional|Apr 2016|Pre-Eclampsia,HELLP Syndrome,Syndrome|\nNCT02758171|Boehringer Ingelheim|Completed|May 2016|Aug 2016|Interventional|Apr 2016||Empagliflozin,Linagliptin\nNCT02755376|Samsung Medical Center|Completed|Jan 2014|Dec 2018|Interventional|Feb 2015||Hyaluronic Acid\nNCT02759016|Boehringer Ingelheim|Completed|Jun 2016|Jul 2019|Interventional|Apr 2016|Leukemia|BI 836826\nNCT02758457|University of Bologna|Completed|Jan 2008|Apr 2015|Interventional|Apr 2016||\nNCT02755519|Chongqing Medical University|Completed|May 2014|Oct 2016|Observational|Apr 2016|Hyperaldosteronism|\nNCT02758782|Charite University, Berlin, Germany|Completed|Sep 2016|Jan 2021|Interventional|Apr 2016|Spondylitis|Celecoxib,Golimumab\nNCT02756806|Cutera Inc.|Completed|Apr 2016|Sep 2016|Interventional|Apr 2016||\nNCT02756156|Kahramanmaras Sutcu Imam University|Unknown status|Apr 2016|Aug 2016|Observational|Mar 2016|Humeral Fractures|\nNCT02759458|Rush University Medical Center|Completed|Nov 2013|Jan 2017|Interventional|Apr 2016|Rotator Cuff Injuries|\nNCT02750982|Brown, Theodore R., M.D., MPH|Completed|Jul 2016|Aug 2018|Interventional|Apr 2016|Parkinson Disease,Multiple Sclerosis,Alzheimer Disease,Brain Injuries,Spinal Cord Injuries,Motor Neuron Disease,Amyotrophic Lateral Sclerosis,Huntington Disease,Sclerosis,Wounds and Injuries|\nNCT02751502|NYU Langone Health|Terminated|Jan 2017|Feb 2021|Interventional|Apr 2016|Hemiplegia|\nNCT02752087|Eli Lilly and Company|Completed|Apr 2016|May 2016|Interventional|Apr 2016||\nNCT02756858|Anavex Life Sciences Corp.|Completed|Mar 2016|Nov 2020|Interventional|Mar 2016|Alzheimer Disease|\nNCT02758249|Konkuk University Medical Center|Completed|Jan 2016|Jan 2016|Interventional|Feb 2016||Propofol,Sevoflurane\nNCT02754570|University of Colorado, Denver|Completed|Jul 2016|Feb 2018|Interventional|Apr 2016|Glaucoma,Ocular Hypertension,Hypertension|Pilocarpine\nNCT02754102|Bayer|Completed|May 2016|May 2016|Interventional|Apr 2016|Dermatitis|Sunscreening Agents\nNCT02751593|Peking University People's Hospital|Unknown status|Jan 2016|Dec 2017|Interventional|Apr 2016|Thrombocytopenia,Purpura|Dexamethasone\nNCT02757014|Bayer|Completed|Oct 2015|Oct 2015|Interventional|Apr 2016||\nNCT02753062|Asan Medical Center|Recruiting|Aug 2015|Aug 2023|Interventional|Apr 2016|Lymphoma|Rituximab,Bendamustine Hydrochloride\nNCT02752425|Hospices Civils de Lyon|Completed|May 2016|May 2018|Interventional|Apr 2016|Speech Disorders|\nNCT02757300|Marienhospital Osnabrück|Unknown status|May 2016|Jul 2017|Interventional|Apr 2016|Pharyngitis|\nNCT02754180|Peking Union Medical College Hospital|Unknown status|Mar 2016|Mar 2021|Interventional|Apr 2016|Adenocarcinoma,Pancreatic Neoplasms|Gemcitabine\nNCT02752321|Northwell Health|Terminated|Aug 2016|Dec 2017|Interventional|Apr 2016||\nNCT02753595|Eisai Inc.|Terminated|Jul 2016|Aug 2019|Interventional|Apr 2016|Breast Neoplasms|\nNCT02755246|Charite University, Berlin, Germany|Completed|Apr 2016|Sep 2016|Interventional|Apr 2016|Cognitive Dysfunction|\nNCT02754115|Tata Memorial Centre|Recruiting|Apr 2016|Jan 2022|Observational|Mar 2016|Peritoneal Diseases|\nNCT02756897|M.D. Anderson Cancer Center|Active, not recruiting|Jul 2016|Jul 2024|Interventional|Apr 2016|Lymphoma,Leukemia|Venetoclax\nNCT02752334|Magrabi Eye & Ear Hospital|Completed|Sep 2015|Mar 2019|Interventional|Mar 2016||Magnesium Sulfate,Bupivacaine\nNCT02754791|Shaare Zedek Medical Center|Unknown status|May 2016|May 2017|Interventional|Apr 2016||\nNCT02754128|Holland Bloorview Kids Rehabilitation Hospital|Completed|Jun 2016|Oct 2017|Interventional|Apr 2016|Cerebral Palsy|\nNCT02751190|Umeå University|Completed|Sep 2013|Feb 2017|Observational [Patient Registry]|Apr 2016|Chronic Pain,Hernia|\nNCT02751645|Oregon Health and Science University|Unknown status|Jun 2016|May 2020|Interventional|Apr 2016||\nNCT02758184|Duke University|Terminated|Jun 2016|May 2018|Interventional|Apr 2016||\nNCT02751892|University of East Anglia|Completed|Oct 2013|Sep 2014|Interventional|Apr 2016|Colorectal Neoplasms|\nNCT02755324|Leiden University|Completed|Oct 2016|Jan 2019|Interventional|Apr 2016|Schistosomiasis|\nNCT02758886|Washington State University|Completed|Apr 2014||Interventional|Apr 2016|Stress|\nNCT02750072|Fraser Orthopaedic Research Society|Active, not recruiting|Sep 2016|Apr 2023|Interventional|Apr 2016|Patellofemoral Pain Syndrome,Fractures,Tibial Fractures|\nNCT02750332|Cycle Pharmaceuticals Ltd.|Completed|Nov 2015|Jan 2016|Interventional|Apr 2016|Tyrosinemias|Nitisinone\nNCT02752529|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine|Unknown status|Mar 2016||Interventional|Mar 2016|Liver Cirrhosis|Tacrolimus\nNCT02759939|Dartmouth-Hitchcock Medical Center|Completed|Jul 2016|Jul 2017|Interventional|Feb 2016||\nNCT02757157|European Respiratory Society|Terminated|Oct 2016|Jan 2020|Interventional|Apr 2016|Lung Diseases,Pulmonary Disease|\nNCT02759627|Istanbul University|Completed|Nov 2014|Mar 2016|Interventional|Apr 2016|Stroke|\nNCT02752412|Sanofi|Completed|May 2016|Oct 2018|Interventional|Apr 2016|Diabetes Mellitus|Insulin,Metformin,Insulin Glargine,Lixisenatide\nNCT02756988|Bayer|Completed|Oct 2015|Oct 2015|Interventional|Apr 2016||\nNCT02751203|Lara McKenzie|Completed|Apr 2016|Dec 2017|Interventional|Mar 2016||\nNCT02753946|Nabriva Therapeutics AG|Completed|Apr 2016|May 2017|Interventional|Apr 2016|Infections,Communicable Diseases,Urinary Tract Infections,Pyelonephritis|Tazobactam,Piperacillin,Fosfomycin\nNCT02755480|University Health Network, Toronto|Terminated|Feb 2015|Feb 2017|Interventional|Mar 2015||\nNCT02753257|Valtari Bio|Unknown status|Sep 2016|Dec 2019|Observational|Apr 2016|Stroke|\nNCT02758691|Virginia Polytechnic Institute and State University|Completed|Dec 2015|May 2017|Interventional|Apr 2016||Insulin\nNCT02755623|Centre hospitalier de Ville-Evrard, France|Unknown status|May 2015|Dec 2018|Interventional|Apr 2016|Hallucinations,Schizophrenia|\nNCT02756234|Lancaster General Hospital|Completed|May 2016|Aug 2018|Observational|Apr 2016|Coronary Artery Disease|\nNCT02756091|University Hospital Inselspital, Berne|Recruiting|Aug 2016|May 2022|Observational [Patient Registry]|Apr 2016|Cerebrovascular Disorders|\nNCT02753491|Marmara University|Completed|Oct 2015|Mar 2016|Interventional|Apr 2016||\nNCT02752737|Medtronic Cardiac Rhythm and Heart Failure|Recruiting|May 2016|Dec 2024|Observational [Patient Registry]|Apr 2016|Atrial Fibrillation|\nNCT02758925|University Hospital, Caen|Unknown status|Jun 2016|Dec 2018|Interventional|Apr 2016|Lymphoma|Cytarabine,Rituximab,Bendamustine Hydrochloride\nNCT02751723|Florian Lordick, MD|Unknown status|Sep 2014|Oct 2019|Observational|Apr 2016||\nNCT02751931|Astellas Pharma Europe B.V.|Completed|Jun 2016|May 2019|Interventional|Apr 2016|Urinary Bladder|Mirabegron\nNCT02758847|Rabih A. Chaer|Recruiting|Sep 2016|Dec 2022|Interventional|Apr 2016|Ischemia|Paclitaxel,Albumin-Bound Paclitaxel\nNCT02757807|Eco Fusion|Unknown status|Jul 2016|Dec 2016|Interventional|Apr 2016|Erectile Dysfunction|\nNCT02755220|Shanghai Cingularbio Co. Ltd|Completed|Jan 2016|Apr 2019|Interventional|Apr 2016||\nNCT02758548|Novartis Pharmaceuticals|Completed|Mar 2016|May 2016|Interventional|Mar 2016||\nNCT02756845|Amgen|Recruiting|Aug 2017|Jun 2024|Interventional|Dec 2015|Neoplasms|Talimogene laherparepvec\nNCT02750605|Skane University Hospital|Active, not recruiting|Feb 2016|Dec 2021|Interventional|Jan 2016|Vascular Diseases,Peripheral Vascular Diseases,Peripheral Arterial Disease,Ischemia|\nNCT02756702|Aesculap AG|Active, not recruiting|Mar 2016|Dec 2022|Observational|Apr 2016|Osteoarthritis|\nNCT02752945|King's College London|Completed|Apr 2016|Dec 2016|Interventional|Apr 2016|Depression,Depressive Disorder,Anxiety Disorders|\nNCT02759952|STZ eyetrial|Enrolling by invitation|Jan 2013|Dec 2025|Observational|Apr 2016|Retinitis,Retinitis Pigmentosa|\nNCT02754661|Medtronic - MITG|Completed|Sep 2016|Aug 2018|Interventional|Apr 2016|Colorectal Neoplasms|\nNCT02755441|Nils Hoyer|Recruiting|Apr 2016|Dec 2024|Observational|Apr 2016|Pulmonary Fibrosis,Idiopathic Pulmonary Fibrosis,Fibrosis|\nNCT02750098|Sheba Medical Center|Unknown status|May 2016|Mar 2018|Interventional|Apr 2016|Diabetes Mellitus|\nNCT02753179|Hospices Civils de Lyon|Completed|May 2016|Jan 2017|Interventional|Apr 2016|Vestibular Diseases|\nNCT02758509|Parc de Salut Mar|Completed|Jan 2010|Oct 2017|Observational|Apr 2016|Hepatitis C,Hepatitis|Interferons,Ritonavir,Ribavirin,Interferon-alpha,Interferon alpha-2,Sofosbuvir,Peginterferon alfa-2a,Ledipasvir,Simeprevir\nNCT02751970|Universidad de Valparaiso|Unknown status|Apr 2014|Apr 2018|Interventional|Apr 2016|Dental Caries|\nNCT02753712|Mundipharma Research Limited|Completed|Jun 2016|Aug 2017|Interventional|Apr 2016|Asthma|Fluticasone,Xhance,Formoterol Fumarate\nNCT02751151|Inova Health Care Services|Completed|Feb 2016|May 2021|Interventional|Mar 2016|Skin Neoplasms|Aminolevulinic Acid\nNCT02757716|Sana Klinikum Offenbach|Completed|Apr 2016|Jan 2019|Interventional|Apr 2016|Behavior|\nNCT02758652|Tampere University Hospital|Active, not recruiting|May 2016|May 2026|Observational|Apr 2016|Ovarian Neoplasms,Carcinoma|\nNCT02754206|Southern Methodist University|Terminated|Jan 2016|Sep 2021|Observational|Apr 2016|Post-Concussion Syndrome,Brain Concussion|\nNCT02752243|Peter Bader|Active, not recruiting|Mar 2016|Mar 2022|Interventional|Mar 2016|Leukemia,Preleukemia,Myelodysplastic Syndromes,Syndrome,Acute Disease|\nNCT02754856|M.D. Anderson Cancer Center|Active, not recruiting|Jul 2016|Jul 2021|Interventional|Apr 2016|Colorectal Neoplasms|Durvalumab,Ipilimumab,Tremelimumab,Immunoglobulins,Antibodies,Immunoglobulin G\nNCT02759861|University of Nebraska|Active, not recruiting|Aug 2016|Aug 2020|Interventional|Apr 2016|Hepatitis A,Hepatitis C,Hepatitis|Sofosbuvir,Ledipasvir\nNCT02759679|Haukeland University Hospital|Unknown status|May 2016|Dec 2019|Interventional|Mar 2016|Lung Neoplasms|\nNCT02752932|Lawson Health Research Institute|Completed|Nov 2015|Oct 2017|Interventional|Feb 2016|Carcinoma,Squamous Cell Carcinoma of Head and Neck,Neoplasms|\nNCT02759445|RWTH Aachen University|Unknown status|Apr 2016|Oct 2016|Observational|Nov 2015||\nNCT02754622|Guy's and St Thomas' NHS Foundation Trust|Completed|Jul 2016|Dec 2016|Observational|Apr 2016|Critical Illness|\nNCT02756611|AbbVie|Active, not recruiting|Jun 2016|Sep 2022|Interventional|Apr 2016|Leukemia|Venetoclax\nNCT02758223|Wuerzburg University Hospital|Active, not recruiting|Apr 2016|Jun 2021|Interventional|Feb 2016|Leukemia,Myelodysplastic Syndromes|\nNCT02757079|Nobelpharma|Completed|Jun 2016|Jul 2018|Interventional|Apr 2016|Sleep Wake Disorders,Parasomnias,Disease,Neurodevelopmental Disorders|Melatonin\nNCT02754219|Dong-A ST Co., Ltd.|Completed|Sep 2016|Jan 2018|Interventional|Apr 2016|Liver Diseases|\nNCT02753101|Stanford University|Completed|Feb 2016|Feb 2017|Interventional|Apr 2016|Complex Regional Pain Syndromes,Reflex Sympathetic Dystrophy,Sciatica|\nNCT02759003|Fondazione Salvatore Maugeri|Completed|Mar 2011|Mar 2014|Interventional|Apr 2016|Motor Neuron Disease,Amyotrophic Lateral Sclerosis,Sclerosis|\nNCT02752659|University of British Columbia|Completed|Jun 2016|Jun 2017|Interventional|Apr 2016|Breast Neoplasms,Lymphedema|\nNCT02758912|Burnasyan Federal Medical Biophysical Center|Completed|Nov 2016|Oct 2019|Interventional|Apr 2016|Stroke,Angina Pectoris,Infarction,Hemorrhage|\nNCT02754388|National Taiwan University Hospital|Completed|Feb 2016|Dec 2019|Observational [Patient Registry]|Apr 2016|Lung Neoplasms|\nNCT02759666|Atridia Pty Ltd.|Completed|Jun 2016|Apr 2019|Interventional|Apr 2016|Neoplasms|\nNCT02750241|The University of Texas Medical Branch, Galveston|Completed|Apr 2016|Jan 2019|Interventional|Apr 2016|Breast Neoplasms|\nNCT02752568|Kasr El Aini Hospital|Unknown status|May 2016|Dec 2016|Interventional|Apr 2016||\nNCT02758015|University of California, San Francisco|Completed|Jun 2016|Mar 2018|Interventional|Apr 2016||Betaine\nNCT02756884|Arkansas Heart Hospital|Completed|Jun 2015|Jan 2019|Interventional|Apr 2016|Peripheral Arterial Disease,Peripheral Vascular Diseases|\nNCT02758353|JSI Research & Training Institute, Inc.|Completed|Apr 2015|Nov 2015|Interventional|Apr 2016|Malaria,Stillbirth|\nNCT02753751|Yale University|Completed|Mar 2018|Jan 2020|Interventional|Apr 2016|Acute Kidney Injury,Wounds and Injuries|\nNCT02757170|All India Institute of Medical Sciences, New Delhi|Unknown status|Jul 2015|Jul 2016|Interventional|Apr 2016|Liver Failure,Hepatic Insufficiency,End Stage Liver Disease,Acute-On-Chronic Liver Failure|\nNCT02757625|Pfizer|Completed|Jul 2016|May 2017|Interventional|Apr 2016||Dexmedetomidine\nNCT02752347|Riyadh Colleges of Dentistry and Pharmacy|Unknown status|Apr 2016|Dec 2017|Interventional|Apr 2016|Malocclusion|\nNCT02756468|University of Roma La Sapienza|Unknown status|Jan 2015|Dec 2016|Observational [Patient Registry]|Apr 2016|Pancreatic Neoplasms|\nNCT02750410|Eli Lilly and Company|Completed|Aug 2016|\n\n*** WARNING: max output size exceeded, skipping output. ***\n\nst Neoplasms|\nNCT02758990|Verifomics LLC|Terminated|Mar 2016|Nov 2016|Interventional|Apr 2016|Rhinitis,Arthralgia,Dyspnea,Sleep Deprivation,Migraine Disorders,Sleep Initiation and Maintenance Disorders,Disease,Headache,Respiratory Sounds|Vitamin D,Cholecalciferol,Vitamins,Ascorbic Acid,Vitamin E,Tocopherols,Vitamin A,Niacinamide,Niacin,Nicotinic Acids,Pyridoxine,Pyridoxal,Vitamin B 6,Caffeine\nNCT02754193|Central Hospital, Nancy, France|Completed|Oct 2016|Nov 2019|Interventional|Apr 2016|Shock,Hypothermia|\nNCT02758613|Eli Lilly and Company|Completed|May 2016|Jul 2016|Interventional|Apr 2016||\nNCT02751047|Seoul National University Hospital|Completed|May 2016|Jan 2017|Interventional|Apr 2016||\nNCT02758197|Ottawa Hospital Research Institute|Completed|Jul 2016|Oct 2020|Interventional|Apr 2016|Neuralgia,Chronic Pain|\nNCT02753270|University of Sao Paulo|Completed|Dec 2014|Apr 2017|Interventional|Apr 2016|Varicose Veins|\nNCT02750839|Azienda Ospedaliera Bolognini di Seriate Bergamo|Unknown status|Apr 2016|Apr 2016|Observational|Apr 2016|Osteoporosis,Fractures,Humeral Fractures|\nNCT02750488|Bayer|Completed|May 2016|Jul 2016|Interventional|Apr 2016|Dermatitis|\nNCT02752958|GlaxoSmithKline|Completed|May 2016|Feb 2017|Interventional|Apr 2016|Dentin Sensitivity,Hypersensitivity|Fluorides,Tin Fluorides\nNCT02753322|The Queen Elizabeth Hospital|Unknown status|Apr 2016|Mar 2018|Interventional|Apr 2016|Stroke|\nNCT02757261|University of Nove de Julho|Unknown status|Jun 2016|Mar 2017|Interventional|Apr 2016|Bruxism,Sleep Bruxism|Salicylic Acid\nNCT02754427|University of British Columbia|Completed|Feb 2013|Aug 2015|Interventional|Apr 2016|Breast Neoplasms|\nNCT02758366|Meyer Children's Hospital|Terminated|Feb 2016|Jan 2020|Interventional|Apr 2016|Glioblastoma,Glioma,Astrocytoma,Diffuse Intrinsic Pontine Glioma,Neoplasms|Doxorubicin\nNCT02755402|Centre hospitalier de l'Université de Montréal (CHUM)|Completed|Jan 2017|May 2021|Interventional|Apr 2016|Hepatitis C|\nNCT02754453|The Cleveland Clinic|Withdrawn|Jul 2013|Oct 2015|Interventional|Sep 2013|Body Weight,Weight Loss|\nNCT02755103|Medical University of South Carolina|Active, not recruiting|Jun 2016|Oct 2021|Interventional|Apr 2016|Disease,Substance-Related Disorders,Stress Disorders|\nNCT02758834|Università Politecnica delle Marche|Completed|Jan 2014|Apr 2016|Observational|Apr 2016|Liver Diseases|\nNCT02759146|Michigan State University|Completed|May 2016|Nov 2019|Interventional|Apr 2016||\nNCT02754414|Bloodworks|Unknown status|Apr 2016|Jan 2019|Interventional|Apr 2016||\nNCT02759783|Royal Marsden NHS Foundation Trust|Active, not recruiting|Nov 2016|Oct 2024|Interventional|Apr 2016|Carcinoma|\nNCT02756923|Weill Medical College of Cornell University|Suspended|Apr 2012|Dec 2025|Observational|Apr 2016|Infertility|\nNCT02759237|Medtronic Cardiovascular|Terminated|Feb 2016|May 2017|Observational|Apr 2016|Aortic Valve Stenosis|\nNCT02757391|M.D. Anderson Cancer Center|Terminated|Aug 2019|Oct 2020|Interventional|Apr 2016|Carcinoma,Colorectal Neoplasms,Adenocarcinoma,Stomach Neoplasms,Esophageal Neoplasms,Cholangiocarcinoma|Aldesleukin,Cyclophosphamide,Pembrolizumab,Interleukin-2,Immunologic Factors\nNCT02750904|Fred Hutchinson Cancer Research Center|Completed|Apr 2017|May 2019|Interventional|Mar 2016|Disease,Bipolar Disorder|Nicotine\nNCT02758418|Universitat Jaume I|Unknown status|Apr 2016|Jul 2019|Interventional|Apr 2016|Adjustment Disorders|\nNCT02756039|AstraZeneca|Completed|May 2016|Aug 2018|Observational|Apr 2016||\nNCT02755077|Massachusetts General Hospital|Completed|Jul 2014|Jan 2016|Interventional|Apr 2016||\nNCT02751801|Sheffield Teaching Hospitals NHS Foundation Trust|Completed|Nov 2016|Dec 2017|Observational|Apr 2016|Hypophosphatasia|\nNCT02751177|Institut de Cancérologie de Lorraine|Completed|Mar 2016|May 2017|Interventional|Mar 2016|Colorectal Neoplasms|\nNCT02758574|University of Pittsburgh|Completed|May 2016|Aug 2021|Interventional|Mar 2016|Pulmonary Embolism,Embolism|\nNCT02758587|NHS Greater Glasgow and Clyde|Recruiting|Jul 2017|Dec 2021|Interventional|Apr 2016|Mesothelioma,Carcinoma,Pancreatic Neoplasms|Pembrolizumab\nNCT02752100|Third Military Medical University|Unknown status|Mar 2016|May 2020|Interventional|Mar 2016|Arterial Occlusive Diseases|\nNCT02755818|University of California, Davis|Terminated|Oct 2008|Feb 2019|Observational|Mar 2016|Insulin Resistance|Heparin,Calcium heparin\nNCT02752906|Sanofi Pasteur, a Sanofi Company|Completed|Apr 2016|Dec 2016|Interventional|Apr 2016|Meningococcal Infections,Meningitis|Vaccines\nNCT02750371|University Hospital, Bordeaux|Active, not recruiting|Jul 2016|Oct 2021|Interventional|Apr 2016|Adenoma,Meningioma,Pituitary Neoplasms,Pituitary Diseases|\nNCT02751125|University of Bergen|Completed|Jun 2014|Mar 2020|Interventional|Mar 2016|Atrophy|\nNCT02754700|High Point University|Completed|Apr 2016|Feb 2019|Interventional|Apr 2016|Knee Injuries|\nNCT02756442|Assistance Publique Hopitaux De Marseille|Unknown status|Apr 2016|Apr 2019|Interventional|Apr 2016|Respiration Disorders,Respiratory Tract Diseases,Diabetes|\nNCT02756637|Abramson Cancer Center of the University of Pennsylvania|Completed|Apr 2016|Nov 2016|Observational|Apr 2016|Urinary Bladder Neoplasms|\nNCT02755688|Royal Brompton & Harefield NHS Foundation Trust|Unknown status|Jun 2015|Mar 2020|Interventional|Apr 2016|Atrial Fibrillation|\nNCT02753387|Rennes University Hospital|Completed|May 2016|Sep 2018|Interventional|Apr 2016|Bacterial Infections,Head and Neck Neoplasms|Chlorhexidine\nNCT02758470|University of British Columbia|Completed|Nov 2016|Jun 2017|Interventional|Apr 2016|Fatigue,Hypoxia|Acetazolamide,Methazolamide\nNCT02754375|Centre Hospitalier Universitaire de Nice|Unknown status|May 2016|May 2019|Interventional|Apr 2016|Depression,Depressive Disorder|\nNCT02758756|University of Rochester|Completed|Jun 2016|May 2019|Interventional|Apr 2016|Fatigue|\nNCT02750787|Abbott Nutrition|Completed|Aug 2016|Jul 2017|Interventional|Apr 2016|Malabsorption Syndromes|\nNCT02757339|Mclean Hospital|Enrolling by invitation|Jun 2015|May 2022|Observational|Mar 2016|Disease,Stress Disorders,Dissociative Disorders,Dissociative Identity Disorder|\nNCT02753959|Guy's and St Thomas' NHS Foundation Trust|Completed|Aug 2016|Sep 2019|Interventional|Apr 2016|Neuromuscular Diseases|\nNCT02753426|University of California, San Francisco|Completed|Apr 2016|Jan 2018|Interventional|Apr 2016|Kidney Diseases,Renal Insufficiency,Cardio-Renal Syndrome|Doxycycline\nNCT02757183|AnalyticsPlus, Inc.|Unknown status|Apr 2016|Mar 2017|Observational|Apr 2016||\nNCT02750293|University of Tromso|Completed|Jun 2015|Sep 2017|Interventional|Apr 2016|Vitamin D Deficiency|Cholecalciferol\nNCT02757274|European Association of Urology Research Foundation|Recruiting|Feb 2017|Jul 2027|Observational [Patient Registry]|Apr 2016|Urinary Incontinence,Enuresis|\nNCT02756741|All India Institute of Medical Sciences, New Delhi|Completed|Apr 2014|Jul 2015|Interventional|Apr 2016|Peritonitis,Fibrosis|\nNCT02758964|Charite University, Berlin, Germany|Completed|Sep 2016|Jan 2019|Observational|Apr 2016|Intracranial Embolism,Embolism,Aortic Valve Stenosis|\nNCT02753439|The Baruch Padeh Medical Center, Poriya|Unknown status|Feb 2017|Feb 2019|Interventional|Mar 2016|Tooth|\nNCT02751281|Isfahan University of Medical Sciences|Completed|Dec 2014|Apr 2016|Interventional|Apr 2016|Kidney Calculi,Nephrolithiasis|\nNCT02756676|Ospedale Generale Di Zona Moriggia-Pelascini|Completed|Apr 2015|Dec 2016|Interventional|Apr 2016|Parkinson Disease|\nNCT02750215|Massachusetts General Hospital|Completed|May 2016|May 2021|Interventional|Apr 2016|Lung Neoplasms|\nNCT02755935|Cochlear|Completed|May 2016|Sep 2017|Interventional|Apr 2016|Hearing Loss|\nNCT02759523|Penn State University|Completed|Jul 2013|Dec 2015|Observational|Apr 2016|Pediatric Obesity|\nNCT02756533|University Hospital, Grenoble|Recruiting|Aug 2016|Aug 2021|Interventional|Mar 2016|Lung Diseases,Pulmonary Disease,Signs and Symptoms|\nNCT02752841|Brown University|Terminated|May 2016|May 2019|Interventional|Apr 2016|Kidney Calculi,Calculi|Vitamin D\nNCT02758392|Janssen Research & Development, LLC|Completed|Apr 2016|Jan 2017|Interventional|Apr 2016||\nNCT02755870|Clene Nanomedicine|Completed|Apr 2015|Oct 2016|Interventional|Apr 2016||\nNCT02752464|Boston Medical Center|Completed|Sep 2016|Jun 2018|Interventional|Apr 2016||\nNCT02756780|Royal Marsden NHS Foundation Trust|Unknown status|Apr 2016|Apr 2018|Interventional|Apr 2016||\nNCT02753998|Assistance Publique - Hôpitaux de Paris|Active, not recruiting|Dec 2016|Sep 2021|Interventional|Apr 2016|Arteriovenous Fistula,Constriction,Fistula|Paclitaxel\nNCT02751307|Taipei Medical University WanFang Hospital|Completed|May 2013|Jan 2015|Interventional|Apr 2016|Congenital Abnormalities,Metabolic Syndrome,Schizophrenia|Metformin,Clozapine\nNCT02757755|Armata Pharmaceuticals, Inc.|Completed|May 2016|Aug 2016|Interventional|Apr 2016||\nNCT02753972|University of New Mexico|Completed|Aug 2006|Jan 2008|Interventional|Apr 2016||\nNCT02751853|University of Luebeck|Unknown status|Dec 2016|Aug 2020|Interventional|Apr 2016|Heart Failure|\nNCT02752971|Hospital Central Dr. Luis Ortega|Completed|Feb 2015||Interventional|Mar 2016|Pain|Diclofenac,Bupivacaine\nNCT02755012|McGill University|Completed|Jun 2012|Nov 2013|Observational|Apr 2016|Infections,Mastitis,Malnutrition,Infant Nutrition Disorders,Growth Disorders,Stress|\nNCT02751996|F-star Therapeutics, Inc.|Completed|May 2016|Feb 2020|Interventional|Apr 2016|Hepatitis A,Hepatitis B,Hepatitis|Tenofovir\nNCT02752893|Dartmouth-Hitchcock Medical Center|Completed|Jan 2017|Apr 2019|Observational|Apr 2016|Breast Neoplasms|\nNCT02753842|Global Protection Corp.|Completed|May 2016|Jul 2017|Interventional|Apr 2016||\nNCT02757040|Peking University People's Hospital|Unknown status|Dec 2016|Dec 2018|Interventional|Apr 2016|Leukemia|Arsenic Trioxide\nNCT02751606|Radboud University|Unknown status|Jun 2015|Nov 2019|Interventional|Nov 2014|Neoplasms,Breast Neoplasms,Rectal Neoplasms|\nNCT02751372|Bayer|Completed|May 2016|May 2016|Interventional|Apr 2016||\nNCT02753764|National Jewish Health|Completed|Jan 2017|Feb 2019|Interventional|Apr 2016|Asthma|Prednisone,AZD7624\nNCT02758938|University of Wisconsin, Madison|Completed|Jun 2016|Sep 2018|Interventional|Dec 2015|Lower Urinary Tract Symptoms|\nNCT02752399|Federal University of São Paulo|Unknown status|Apr 2016|Jun 2017|Observational|Apr 2016|Hypertension,Heart Defects,Eisenmenger Complex|\nNCT02753296|University of Sheffield|Unknown status|May 2016|Jun 2018|Observational|Apr 2016||\nNCT02759432|Teesside University|Completed|May 2016|Jul 2016|Interventional|Apr 2016||\nNCT02750137|KK Women's and Children's Hospital|Completed|Aug 2014|May 2015|Observational|Apr 2016|Drug-Related Side Effects and Adverse Reactions|Tetracaine\nNCT02754466|University of Brasilia|Terminated|May 2017|Sep 2021|Interventional|Apr 2016|Dental Caries|\nNCT02752191|Paul Finn|Recruiting|Apr 2016|Apr 2021|Interventional|Apr 2016|Heart Diseases,Heart Defects|Ferrosoferric Oxide\nNCT02753517|University Hospital, Lille|Recruiting|Dec 2015|Nov 2023|Interventional|Apr 2016|Liver Failure,Hepatic Insufficiency|\nNCT02758054|University of Texas Southwestern Medical Center|Active, not recruiting|Jun 2017|Mar 2023|Interventional|Apr 2016|Carcinoma|\nNCT02757573|Tampere University Hospital|Active, not recruiting|Apr 2016|Dec 2022|Interventional|Apr 2016|Hypercapnia|\nNCT02752789|National Institute of Allergy and Infectious Diseases (NIAID)|Completed|Jul 2014|Nov 2019|Observational|Apr 2016||\nNCT02756416|University of Nottingham|Unknown status|Jul 2016|May 2017|Interventional|Mar 2016|Syndrome|\nNCT02758106|Chung Shan Medical University|Completed|Feb 2014|Nov 2015|Interventional|Apr 2016|Respiratory Insufficiency|\nNCT02759159|Xuanwu Hospital, Beijing|Unknown status|Jun 2016|Dec 2018|Interventional|Apr 2016|Alzheimer Disease|\nNCT02753777|University of Pennsylvania|Recruiting|Apr 2016|Dec 2025|Observational [Patient Registry]|Apr 2016|Pemphigoid,Pemphigus|\nNCT02754245|Baylor Research Institute|Unknown status|Nov 2016|Jul 2017|Observational|Apr 2016|Emergencies|\nNCT02754687|Health Decisions|Unknown status|Apr 2016|Jan 2020|Interventional|Mar 2016||Nandrolone Decanoate,Nandrolone,Nandrolone phenpropionate\nNCT02755337|Dr. Soetomo General Hospital|Unknown status|Jan 2016|Dec 2016|Observational|Apr 2016|Lung Neoplasms|\nNCT02755090|University of New Mexico|Completed|Jul 2016|May 2017|Interventional|Apr 2016||Nitrous Oxide\nNCT02751437|Liverpool Women's NHS Foundation Trust|Completed|Aug 2016|Mar 2018|Interventional|Mar 2016|Premature Birth|\nNCT02757950|GlaxoSmithKline|Completed|Jul 2016|May 2017|Observational|Apr 2016|Diphtheria|\nNCT02756754|University Hospital, Toulouse|Completed|Nov 2016|May 2019|Interventional|Apr 2016|Adenoma,Adrenocortical Adenoma,Hyperaldosteronism|\nNCT02754726|HonorHealth Research Institute|Active, not recruiting|Apr 2016|Jun 2022|Interventional|Apr 2016|Adenocarcinoma|Gemcitabine,Paclitaxel,Nivolumab,Albumin-Bound Paclitaxel\nNCT02759549|Emory University|Withdrawn|Sep 2015||Interventional|Apr 2016|Breast Neoplasms|\nNCT02755714|Haukeland University Hospital|Completed|Jun 2016|Oct 2020|Interventional|Apr 2016||Bromides,Ipratropium\nNCT02750358|Memorial Sloan Kettering Cancer Center|Active, not recruiting|May 2016|May 2022|Interventional|Apr 2016|Breast Neoplasms,Triple Negative Breast Neoplasms|\nNCT02754921|Mohamed Sayed Mohamed Abbas|Completed|Jan 2013||Interventional|Apr 2016||\nNCT02755259|University of Zurich|Completed|Jan 2017|Apr 2019|Interventional|Mar 2016|Hypertension|Acetazolamide\nNCT02759081|Dalin Tzu Chi General Hospital|Completed|Jan 2015||Interventional|Apr 2016||\nNCT02755155|University Hospital, Strasbourg, France|Terminated|Sep 2016|Aug 2019|Interventional|Apr 2016|Hypoalbuminemia,Syndrome,Systemic Inflammatory Response Syndrome|\nNCT02758119|Ilumens|Completed|Jun 2016|Oct 2016|Interventional|Apr 2016|Heart Arrest,Out-of-Hospital Cardiac Arrest|\nNCT02755415|China Medical University Hospital|Unknown status|May 2016|Dec 2017|Interventional|Apr 2016|Stroke|\nNCT02751268|Armed Forces Hampyeong Hospital|Unknown status|Apr 2016|Mar 2017|Interventional|Apr 2016|Psychomotor Agitation,Emergence Delirium|Ropivacaine\nNCT02756572|University of Washington|Completed|Sep 2016|Jul 2020|Interventional|Apr 2016|Leukemia,Neoplasms,Preleukemia,Myelodysplastic Syndromes,Anemia,Syndrome|Cytarabine,Cyclosporine,Mycophenolic Acid,Sirolimus,Fludarabine,Fludarabine phosphate,Melphalan,Mechlorethamine,Mitoxantrone,Nitrogen Mustard Compounds,Cladribine,2-chloro-3-deoxyadenosine,Cyclosporins,Lenograstim\nNCT02756871|Institute of Child Health|Completed|Jul 2015|Feb 2017|Interventional|Apr 2016||\nNCT02750618|Ultragenyx Pharmaceutical Inc|Completed|May 2016|Sep 2019|Interventional|Dec 2015|Familial Hypophosphatemic Rickets,Hypophosphatemia|\nNCT02757196|Peking University People's Hospital|Unknown status|May 2016|Dec 2018|Interventional|Apr 2016|Thrombocytopenia,Purpura|Methylprednisolone,Methylprednisolone Acetate,Methylprednisolone Hemisuccinate,Prednisolone,Prednisolone acetate,Rituximab,Prednisolone hemisuccinate,Prednisolone phosphate\nNCT02758093|University of Alabama at Birmingham|Completed|Sep 2016|Mar 2020|Interventional|Mar 2016||\nNCT02750943|GlaxoSmithKline|Completed|Nov 2015|Mar 2016|Interventional|Nov 2015|Gingivitis|Fluorides,Tin Fluorides,Fluorophosphate\nNCT02754908|The University of Hong Kong|Completed|Jan 2016|Jun 2018|Interventional|Apr 2016|Brain Neoplasms|\nNCT02750514|Bristol-Myers Squibb|Terminated|May 2016|Jan 2020|Interventional|Apr 2016|Carcinoma|Nivolumab,Ipilimumab,Dasatinib,Linrodostat\nNCT02755350|LVCT Health|Unknown status|Aug 2015|Apr 2017|Interventional|Nov 2015||Emtricitabine\nNCT02753374|Beijing Children's Hospital|Not yet recruiting|May 2016|Jul 2030|Observational|Apr 2016|Cystic Fibrosis,Fibrosis|\nNCT02759419|Bayer|Recruiting|Jun 2016|Dec 2023|Interventional|Apr 2016|Pulmonary Arterial Hypertension,Hypertension|Riociguat\nNCT02757612|Universidad de Murcia|Completed|Jun 2015|Jul 2016|Interventional|Apr 2016|Burning Mouth Syndrome,Syndrome,Burns|\nNCT02754297|CHU de Quebec-Universite Laval|Recruiting|Apr 2016|Dec 2026|Interventional|Mar 2016|Neoplasms,Neuroendocrine Tumors,Carcinoid Tumor,Carcinoma|Lutetium Lu 177 dotatate\nNCT02758665|University of Ulm|Active, not recruiting|Sep 2016|Mar 2022|Interventional|Apr 2016|Leukemia|Venetoclax,Obinutuzumab\nNCT02755285|Fujifilm Medical Systems USA, Inc.|Completed|Aug 2016|Oct 2016|Interventional|Apr 2016||\nNCT02757690|Asan Medical Center|Completed|Jan 2015|Feb 2016|Interventional|Apr 2016|Neoplasms,Brain Neoplasms|\nNCT02753218|LEO Pharma|Terminated|Apr 2016|May 2016|Interventional|Apr 2016|Psoriasis|Midazolam\nNCT02754986|University of Hyogo|Completed|Mar 2015||Interventional|Mar 2016|Kidney Diseases,Renal Insufficiency|\nNCT02752048|Taiho Pharmaceutical Co., Ltd.|Completed|May 2016|Oct 2017|Interventional|Apr 2016|Muscular Dystrophies,Muscular Dystrophy|\nNCT02752256|University of Iowa|Completed|Oct 2015|Oct 2017|Observational|Apr 2016||Plasminogen,Tissue Plasminogen Activator\nNCT02756936|Genuine Research Center, Egypt|Completed|Feb 2016|Mar 2016|Interventional|Apr 2016||\nNCT02756000|Clinical Hospital Center Zemun|Unknown status|Jan 2016|Jul 2018|Interventional|Apr 2016|Coronary Artery Disease,Myocardial Ischemia,Coronary Disease,Myocardial Infarction,Infarction|Dobutamine\nNCT02754492|Terumo BCT|Completed|Apr 2016|Feb 2017|Interventional|Apr 2016||\nNCT02757677|Swiss Vision Network|Unknown status|Dec 2015|Dec 2019|Observational|Apr 2016|Glaucoma|\nNCT02752373|Brain Sentinel|Terminated|May 2016|Feb 2017|Observational|Mar 2016|Epilepsy,Seizures|\nNCT02752230|Kettering Health Network|Withdrawn|Nov 2016|Jun 2021|Interventional|Mar 2016|Pain|\nNCT02756728|BioInvent International AB|Terminated|May 2016|Dec 2016|Interventional|Apr 2016|Multiple Myeloma,Neoplasms|Melphalan\nNCT02751658|University Hospital, Montpellier|Completed|Nov 2016|Jul 2019|Interventional|Mar 2016|Otorhinolaryngologic Diseases|\nNCT02754518|University of Chicago|Completed|Apr 2016|Apr 2019|Interventional|Apr 2016|Heart Failure|Valsartan,Sacubitril and valsartan sodium hydrate drug combination\nNCT02759380|Sahlgrenska University Hospital, Sweden|Recruiting|Mar 2016|Oct 2022|Interventional|Apr 2016|Prostatic Neoplasms|Phytoestrogens\nNCT02755649|Regeneron Pharmaceuticals|Completed|Jan 2016|Mar 2017|Interventional|Mar 2016|Dermatitis,Eczema|\nNCT02751827|Institut Bergonié|Completed|Feb 2016|Nov 2019|Observational|Apr 2016||\nNCT02755545|Galderma Laboratories, L.P.|Completed|May 2016|Apr 2017|Interventional|Apr 2016|Acne Vulgaris|Salicylic Acid,Adapalene,Salicylates\nNCT02750345|Cycle Pharmaceuticals Ltd.|Completed|Mar 2016|May 2016|Interventional|Apr 2016|Tyrosinemias|Nitisinone\nNCT02755532|Federal University of São Paulo|Completed|Jan 2014|Oct 2015|Interventional|Apr 2016||Bupivacaine\nNCT02758743|Biohit Oyj|Completed|Apr 2016|May 2017|Interventional|Apr 2016||\nNCT02754947|Nationwide Children's Hospital|Completed|Feb 2015|Mar 2016|Observational|Apr 2016|Respiration Disorders,Respiratory Tract Diseases,Nervous System Diseases,Cardiovascular Diseases|\nNCT02750280|Calvary Hospital, Bronx, NY|Completed|Jun 2015|Dec 2015|Interventional|Apr 2016|Diabetic Foot,Foot Ulcer,Ulcer|\nNCT02756325|NYU Langone Health|Withdrawn|Jun 2016|Jan 2019|Interventional|Apr 2016|Infertility|\nNCT02758717|Academic and Community Cancer Research United|Active, not recruiting|May 2016|May 2024|Interventional|Apr 2016|Lymphoma,Hodgkin Disease|Antineoplastic Agents,Nivolumab,Brentuximab Vedotin,Antibodies,Immunoglobulins,Immunoconjugates\nNCT02751034|Medy-Tox|Completed|Jun 2013|Jan 2014|Interventional|Apr 2015||Lidocaine\nNCT02751476|Action Contre la Faim|Unknown status|Apr 2016|Mar 2017|Interventional|Apr 2016|Malnutrition,Severe Acute Malnutrition,Protein-Energy Malnutrition|Disinfectants\nNCT02755454|University Health Network, Toronto|Completed|Oct 2013|Nov 2018|Interventional|Mar 2016|Lung Neoplasms|\nNCT02752867|Dongfang Hospital Beijing University of Chinese Medicine|Unknown status|Dec 2016|Nov 2019|Interventional|Mar 2016|Cerebral Infarction,Infarction,Cognitive Dysfunction|\nNCT02754830|Eli Lilly and Company|Completed|Apr 2016|Jul 2018|Interventional|Apr 2016|Alzheimer Disease|\nNCT02753738|Medical University of Vienna|Unknown status|Aug 2016||Interventional|Apr 2016||Citalopram\nNCT02750267|University of Virginia|Completed|May 2016|May 2016|Interventional|Apr 2016|Diabetes Mellitus|\nNCT02754999|Prolong Pharmaceuticals|Completed|Mar 2016|May 2017|Interventional|Apr 2016|Anemia|\nNCT02754843|Sonova AG|Completed|Oct 2015||Interventional|Oct 2015|Hearing Loss|\nNCT02759055|HealthPartners Institute|Completed|Oct 2016|Dec 2019|Interventional|Apr 2016|Prediabetic State,Glucose Intolerance|\nNCT02753673|Memorial Sloan Kettering Cancer Center|Completed|Apr 2016|Apr 2020|Observational|Apr 2016||\nNCT02754531|Indonesia University|Completed|May 2016|Jul 2016|Interventional|Apr 2016||\nNCT02750033|Seton Healthcare Family|Withdrawn|Oct 2016|Mar 2017|Observational|Apr 2016|Carcinoma|\nNCT02759133|Centre Antoine Lacassagne|Recruiting|Jun 2016|Nov 2022|Interventional|Apr 2016|Breast Neoplasms|\nNCT02756650|Novartis Pharmaceuticals|Completed|Jun 2016|Jan 2019|Interventional|Mar 2016|Behcet Syndrome|\nNCT02752152|Institut de Recherche pour le Developpement|Completed|Dec 2015|Oct 2020|Interventional|Apr 2016|Hepatitis A,Hepatitis C,Hepatitis B,Syphilis,Hepatitis|\nNCT02751385|Boehringer Ingelheim|Terminated|May 2016|Nov 2017|Interventional|Apr 2016|Carcinoma|Nintedanib,Ethinyl estradiol,Ethinyl Estradiol-Norgestrel Combination\nNCT02751879|Boehringer Ingelheim|Completed|Nov 2016|Sep 2017|Observational|Apr 2016|Carcinoma|\nNCT02756663|Novartis Pharmaceuticals|Withdrawn|Dec 2016|Feb 2021|Interventional|Apr 2016|Multiple Myeloma,Neoplasms|Dexamethasone,Panobinostat\nNCT02756273|Centre Hospitalier Universitaire, Amiens|Recruiting|May 2016|May 2022|Interventional|Apr 2016||\nNCT02755974|Imperial College London|Unknown status|Jan 2009|Apr 2021|Observational|Apr 2016|Lung Diseases,Pulmonary Disease|\nNCT02756507|Babes-Bolyai University|Completed|Jun 2016|Jun 2018|Interventional|Apr 2016|Disease,Depression,Anxiety Disorders,Panic Disorder|\nNCT02750553|Jiangsu HengRui Medicine Co., Ltd.|Completed|Jan 2015||Interventional|Apr 2016||\nNCT02750228|Mednax Center for Research, Education, Quality and Safety|Completed|May 2016|Jun 2020|Observational|Mar 2016|Ductus Arteriosus|\nNCT02751710|Ontario Clinical Oncology Group (OCOG)|Recruiting|Dec 2016|Dec 2022|Interventional|Apr 2016|Breast Neoplasms|\nNCT02753361|Suez Canal University|Completed|May 2016|Dec 2016|Interventional|Apr 2016|Lipoma|\nNCT02753634|Lawson Health Research Institute|Completed|Apr 2015|Jun 2016|Interventional|Mar 2016|Osteoarthritis|\nNCT02759250|argenx|Completed|Feb 2015|Jun 2018|Interventional|Apr 2016|Nasopharyngeal Carcinoma|\nNCT02757482|Celal Bayar University|Completed|Sep 2014|Jun 2015|Interventional|Apr 2016||\nNCT02757105|RedHill Biopharma Limited|Completed|May 2016|Jul 2017|Interventional|Apr 2016|Irritable Bowel Syndrome,Syndrome,Diarrhea|Ondansetron\nNCT02756520|Fresenius Kabi|Completed|Sep 2016|Oct 2018|Observational|Apr 2016|Kidney Diseases,Renal Insufficiency|\nNCT02753309|The University of Texas Health Science Center at San Antonio|Completed|Jun 2016|Mar 2021|Interventional|Apr 2016|Urinary Bladder Neoplasms|Sirolimus\nNCT02756832|Takeda|Completed|Sep 2016|Apr 2018|Observational|Apr 2016|Diabetes Mellitus|Alogliptin\nNCT02758158|University Health Network, Toronto|Completed|Jan 2016|Feb 2017|Interventional|Mar 2016|Thyroid Neoplasms,Thyroid Nodule,Thyroid Diseases|\nNCT02752360|Beijing Friendship Hospital|Unknown status|Apr 2016|Dec 2018|Interventional|Apr 2016|Colonic Neoplasms,Crohn Disease,Diverticulum,Diverticular Diseases,Diverticulosis|\nNCT02757794|Assistance Publique Hopitaux De Marseille|Recruiting|Nov 2016|Jun 2022|Interventional|Apr 2016|Memory Disorders|\nNCT02751346|Washington University School of Medicine|Completed|Jan 2016|Feb 2017|Observational|Apr 2016|Pain|\nNCT02757027|Konkuk University Medical Center|Unknown status|May 2016|Jan 2017|Interventional|Apr 2016||\nNCT02756689|University of Alabama at Birmingham|Completed|Mar 2016|Oct 2017|Interventional|Apr 2016||\nNCT02751164|Intensive Care National Audit & Research Centre|Completed|Apr 2013|May 2016|Observational|Apr 2016|Critical Illness|\nNCT02754765|Médecins Sans Frontières, France|Recruiting|Dec 2016|Aug 2023|Interventional|Apr 2016|Tuberculosis,Bacterial Infections|Moxifloxacin,Levofloxacin,Ofloxacin,Linezolid,Pyrazinamide,Bedaquiline,Clofazimine\nNCT02757729|Amorepacific Corporation|Completed|Oct 2015||Interventional|Apr 2016|Dermatitis,Eczema|\nNCT02751866|University of Cincinnati|Recruiting|Jan 2016|Jul 2023|Interventional|Apr 2016|Overweight,Hyperphagia|\nNCT02759068|Hospices Civils de Lyon|Completed|Nov 2014|May 2017|Interventional|Apr 2016|Consciousness Disorders|\nNCT02752503|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|Un\n"]}}],"execution_count":0},{"cell_type":"code","source":["myDataFrame = spark.read.options(delimiter='|',header=True).csv('/FileStore/tables/clinicaltrial_2021.csv')"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"6f8b40f4-020f-4261-9d28-c07ba4b3ff20"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["myDataFrame.distinct().count()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"39c18e04-58a6-41db-a509-c23d05ee0f40"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[53]: 387261","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[53]: 387261"]}}],"execution_count":0},{"cell_type":"code","source":["myDataFrame1=myDataFrame.filter(\"Type != ''\").groupBy(\"Type\").count().orderBy(\"count\",ascending = False).withColumnRenamed(\"count\",\"frequency\")"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"e412d9c0-5f1f-43ec-a589-7baa9a4defc9"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["myDataFrame1.show(5)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"9bc2c04f-202b-4511-a8cf-00e497650a47"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+--------------------+---------+\n|                Type|frequency|\n+--------------------+---------+\n|      Interventional|   301472|\n|       Observational|    77540|\n|Observational [Pa...|     8180|\n|     Expanded Access|       69|\n+--------------------+---------+\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+--------------------+---------+\n|                Type|frequency|\n+--------------------+---------+\n|      Interventional|   301472|\n|       Observational|    77540|\n|Observational [Pa...|     8180|\n|     Expanded Access|       69|\n+--------------------+---------+\n\n"]}}],"execution_count":0},{"cell_type":"code","source":["from pyspark.sql.functions import *"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"4a37e7a7-3503-4dc8-899f-34a63b4da041"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["myDataFrameNew =myDataFrame.select('Conditions').select(split('Conditions', ',').alias('Conditions')).na.drop().withColumn('Conditions',explode('Conditions'))"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"d1bf6bc5-7daf-45c7-87e6-a0ca226e6885"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["myDataFrameNew.show(5, truncate = False)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"be6a426e-1f6d-4e02-a5cb-a1d1bff9bdf1"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+------------------------+\n|Conditions              |\n+------------------------+\n|Autistic Disorder       |\n|Autism Spectrum Disorder|\n|Diabetes Mellitus       |\n|Tuberculosis            |\n|Lung Diseases           |\n+------------------------+\nonly showing top 5 rows\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+------------------------+\n|Conditions              |\n+------------------------+\n|Autistic Disorder       |\n|Autism Spectrum Disorder|\n|Diabetes Mellitus       |\n|Tuberculosis            |\n|Lung Diseases           |\n+------------------------+\nonly showing top 5 rows\n\n"]}}],"execution_count":0},{"cell_type":"code","source":["myDataFrame2 =myDataFrame.select('Conditions').select(split('Conditions', ',').alias('Conditions')).na.drop().withColumn('Conditions',explode('Conditions')).groupBy('Conditions').count().orderBy('count',ascending=False)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"5dc54ba2-ef52-4d5d-8f60-4ea6b2f3e605"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["myDataFrame2.show(5)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"a2af1062-b4d4-4fcd-876f-6583a09452e0"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+-----------------+-----+\n|       Conditions|count|\n+-----------------+-----+\n|        Carcinoma|13389|\n|Diabetes Mellitus|11080|\n|        Neoplasms| 9371|\n| Breast Neoplasms| 8640|\n|         Syndrome| 8032|\n+-----------------+-----+\nonly showing top 5 rows\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+-----------------+-----+\n|       Conditions|count|\n+-----------------+-----+\n|        Carcinoma|13389|\n|Diabetes Mellitus|11080|\n|        Neoplasms| 9371|\n| Breast Neoplasms| 8640|\n|         Syndrome| 8032|\n+-----------------+-----+\nonly showing top 5 rows\n\n"]}}],"execution_count":0},{"cell_type":"markdown","source":["MESH"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"2e781b11-3011-44a6-af05-153c5020cb2b"}}},{"cell_type":"code","source":["dbutils.fs.ls('/FileStore/tables/mesh.csv')"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"1acf6e3c-be01-4568-b7f5-2814089d716c"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[61]: [FileInfo(path='dbfs:/FileStore/tables/mesh.csv', name='mesh.csv', size=5295548, modificationTime=1651704959000)]","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[61]: [FileInfo(path='dbfs:/FileStore/tables/mesh.csv', name='mesh.csv', size=5295548, modificationTime=1651704959000)]"]}}],"execution_count":0},{"cell_type":"code","source":["CreateDFMesh = spark.read.options(delimeter=',', header= True).csv('/FileStore/tables/mesh.csv')"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"dbf0d3d0-2845-4762-b914-9928cb6e513e"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["CreateDFMesh.show(5)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"a923577f-d668-425f-a910-84320bd34477"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+----------+-------------------+\n|      term|               tree|\n+----------+-------------------+\n|Calcimycin|D03.633.100.221.173|\n|   A-23187|D03.633.100.221.173|\n|   Temefos|D02.705.400.625.800|\n|   Temefos|D02.705.539.345.800|\n|   Temefos|D02.886.300.692.800|\n+----------+-------------------+\nonly showing top 5 rows\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+----------+-------------------+\n|      term|               tree|\n+----------+-------------------+\n|Calcimycin|D03.633.100.221.173|\n|   A-23187|D03.633.100.221.173|\n|   Temefos|D02.705.400.625.800|\n|   Temefos|D02.705.539.345.800|\n|   Temefos|D02.886.300.692.800|\n+----------+-------------------+\nonly showing top 5 rows\n\n"]}}],"execution_count":0},{"cell_type":"code","source":["DataFrameTree = CreateDFMesh.withColumn('tree',substring ('tree',0,3).alias('tree'))"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"93f01563-5e00-455d-ba55-476321a882f4"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["DataFrameTree.show(10, truncate = False)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"6b9e78d4-2666-4940-9fd1-39ccccefd7f0"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+----------+----+\n|term      |tree|\n+----------+----+\n|Calcimycin|D03 |\n|A-23187   |D03 |\n|Temefos   |D02 |\n|Temefos   |D02 |\n|Temefos   |D02 |\n|Abate     |D02 |\n|Abate     |D02 |\n|Abate     |D02 |\n|Difos     |D02 |\n|Difos     |D02 |\n+----------+----+\nonly showing top 10 rows\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+----------+----+\n|term      |tree|\n+----------+----+\n|Calcimycin|D03 |\n|A-23187   |D03 |\n|Temefos   |D02 |\n|Temefos   |D02 |\n|Temefos   |D02 |\n|Abate     |D02 |\n|Abate     |D02 |\n|Abate     |D02 |\n|Difos     |D02 |\n|Difos     |D02 |\n+----------+----+\nonly showing top 10 rows\n\n"]}}],"execution_count":0},{"cell_type":"code","source":["AddDataFrame = DataFrameTree.join(myDataFrameNew, DataFrameTree.term == myDataFrameNew.Conditions).select(DataFrameTree[\"*\"],myDataFrameNew[\"*\"])"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"e60eef0f-8084-46d6-9f1c-7e6d9b5a15c7"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["AddDataFrame.show(20)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"b12e1d1f-2b03-4c4e-b753-9b97b55a5d99"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+--------------------+----+--------------------+\n|                term|tree|          Conditions|\n+--------------------+----+--------------------+\n|   Autistic Disorder| F03|   Autistic Disorder|\n|Autism Spectrum D...| F03|Autism Spectrum D...|\n|   Diabetes Mellitus| C19|   Diabetes Mellitus|\n|   Diabetes Mellitus| C18|   Diabetes Mellitus|\n|        Tuberculosis| C01|        Tuberculosis|\n|       Lung Diseases| C08|       Lung Diseases|\n|Diverticular Dise...| C06|Diverticular Dise...|\n|        Diverticulum| C23|        Diverticulum|\n|        Diverticulum| C06|        Diverticulum|\n|      Diverticulosis| C23|      Diverticulosis|\n|      Diverticulosis| C06|      Diverticulosis|\n|              Asthma| C20|              Asthma|\n|              Asthma| C08|              Asthma|\n|              Asthma| C08|              Asthma|\n|              Asthma| C08|              Asthma|\n|     Hypoventilation| C23|     Hypoventilation|\n|     Hypoventilation| C08|     Hypoventilation|\n|            Lymphoma| C20|            Lymphoma|\n|            Lymphoma| C15|            Lymphoma|\n|            Lymphoma| C04|            Lymphoma|\n+--------------------+----+--------------------+\nonly showing top 20 rows\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+--------------------+----+--------------------+\n|                term|tree|          Conditions|\n+--------------------+----+--------------------+\n|   Autistic Disorder| F03|   Autistic Disorder|\n|Autism Spectrum D...| F03|Autism Spectrum D...|\n|   Diabetes Mellitus| C19|   Diabetes Mellitus|\n|   Diabetes Mellitus| C18|   Diabetes Mellitus|\n|        Tuberculosis| C01|        Tuberculosis|\n|       Lung Diseases| C08|       Lung Diseases|\n|Diverticular Dise...| C06|Diverticular Dise...|\n|        Diverticulum| C23|        Diverticulum|\n|        Diverticulum| C06|        Diverticulum|\n|      Diverticulosis| C23|      Diverticulosis|\n|      Diverticulosis| C06|      Diverticulosis|\n|              Asthma| C20|              Asthma|\n|              Asthma| C08|              Asthma|\n|              Asthma| C08|              Asthma|\n|              Asthma| C08|              Asthma|\n|     Hypoventilation| C23|     Hypoventilation|\n|     Hypoventilation| C08|     Hypoventilation|\n|            Lymphoma| C20|            Lymphoma|\n|            Lymphoma| C15|            Lymphoma|\n|            Lymphoma| C04|            Lymphoma|\n+--------------------+----+--------------------+\nonly showing top 20 rows\n\n"]}}],"execution_count":0},{"cell_type":"code","source":["AddDataFrame1 = AddDataFrame.select('tree').alias('tree').na.drop().groupBy('tree').count().orderBy('count', ascending = False)\n"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"1a402986-5980-4ce2-87a9-8d9ff15f918a"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["AddDataFrame1.show(5)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"c49d2a4c-1a7c-43af-aaa9-21cdb763d4af"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+----+------+\n|tree| count|\n+----+------+\n| C04|143994|\n| C23|136079|\n| C01|106674|\n| C14| 94523|\n| C10| 92310|\n+----+------+\nonly showing top 5 rows\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+----+------+\n|tree| count|\n+----+------+\n| C04|143994|\n| C23|136079|\n| C01|106674|\n| C14| 94523|\n| C10| 92310|\n+----+------+\nonly showing top 5 rows\n\n"]}}],"execution_count":0},{"cell_type":"code","source":["dbutils.fs.ls('/FileStore/tables/pharma.csv')"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"4490276c-5b55-481a-bda7-11b6327327fe"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[70]: [FileInfo(path='dbfs:/FileStore/tables/pharma.csv', name='pharma.csv', size=678999, modificationTime=1651704940000)]","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[70]: [FileInfo(path='dbfs:/FileStore/tables/pharma.csv', name='pharma.csv', size=678999, modificationTime=1651704940000)]"]}}],"execution_count":0},{"cell_type":"code","source":["SponsorDF = spark.read.options(delimiter= ',', header = True).csv('/FileStore/tables/pharma.csv')"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"4f0d4725-cdec-4f29-a78f-4bf2fe0906ac"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["SponsorDF.show(15)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"a64b736d-e4f9-48d8-9089-b57046346954"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+--------------------+--------------------+--------------+------------------------+---------------------------------------------------------+------------+------------+--------------------+--------------------+--------------------+--------------------+-------------------+-------------+--------------------+------------------+---------------------+-----+---------------+-----------------------------+------------------+--------------+------------+--------------------+-----+----------+--------------------+--------------------+------------------+-------------------+---------------------------+------------------------+---------------------------+--------------------+--------------------+\n|             Company|      Parent_Company|Penalty_Amount|Subtraction_From_Penalty|Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting|Penalty_Year|Penalty_Date|       Offense_Group|     Primary_Offense|   Secondary_Offense|         Description|Level_of_Government|  Action_Type|              Agency|    Civil/Criminal|Prosecution_Agreement|Court|        Case_ID|Private_Litigation_Case_Title|Lawsuit_Resolution|Facility_State|        City|             Address|  Zip|NAICS_Code|   NAICS_Translation|HQ_Country_of_Parent|HQ_State_of_Parent|Ownership_Structure|Parent_Company_Stock_Ticker|Major_Industry_of_Parent|Specific_Industry_of_Parent|         Info_Source|               Notes|\n+--------------------+--------------------+--------------+------------------------+---------------------------------------------------------+------------+------------+--------------------+--------------------+--------------------+--------------------+-------------------+-------------+--------------------+------------------+---------------------+-----+---------------+-----------------------------+------------------+--------------+------------+--------------------+-----+----------+--------------------+--------------------+------------------+-------------------+---------------------------+------------------------+---------------------------+--------------------+--------------------+\n| Abbott Laboratories| Abbott Laboratories|    $5,475,000|                      $0|                                               $5,475,000|        2013|    20131227|government-contra...|False Claims Act ...|kickbacks and bri...|Abbott Laboratori...|            federal|agency action|Justice Departmen...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          Illinois|    publicly traded|                        ABT|         pharmaceuticals|            pharmaceuticals|https://www.justi...|                null|\n|Abbott Laboratori...|              AbbVie|$1,500,000,000|                      $0|                                           $1,500,000,000|        2012|    20120507|healthcare-relate...|off-label or unap...|                null|Global Health Car...|            federal|agency action|Food and Drug Adm...|civil and criminal|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          Illinois|    publicly traded|                       ABBV|         pharmaceuticals|            pharmaceuticals|http://www.justic...|                null|\n|Abbott Laboratori...|              AbbVie|  $126,500,000|                      $0|                                             $126,500,000|        2010|    20101207|government-contra...|False Claims Act ...|                null|Abbott Laboratori...|            federal|agency action|Justice Departmen...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          Illinois|    publicly traded|                       ABBV|         pharmaceuticals|            pharmaceuticals|https://www.justi...|                null|\n|Abbott Laboratori...| Abbott Laboratories|       $49,045|                      $0|                                                  $49,045|        2009|    20090305|employment-relate...|wage and hour vio...|Fair Labor Standa...|                null|            federal|agency action|Labor Department ...|             civil|                 null| null|        1527129|                         null|              null|   Puerto Rico|    San Juan|                null| null|    423450|423450: Medical, ...|                 USA|          Illinois|    publicly traded|                        ABT|         pharmaceuticals|            pharmaceuticals|March 7, 2017 dow...|Date and year are...|\n|      Acclarent Inc.|   Johnson & Johnson|   $18,000,000|                      $0|                                              $18,000,000|        2016|    20160722|government-contra...|False Claims Act ...|                null|California-based ...|            federal|agency action|Justice Departmen...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|        New Jersey|    publicly traded|                        JNJ|         pharmaceuticals|            pharmaceuticals|https://www.justi...|                null|\n|Advanced Medical ...| Abbott Laboratories|       $16,800|                      $0|                                                  $16,800|        2004|    20040412|employment-relate...|labor relations v...|                null|back pay award in...|            federal|agency action|National Labor Re...|             civil|                 null| null|21-CA-36104-001|                         null|              null|    California|      Irvine|                null|92606|    333314|333314: Optical I...|                 USA|          Illinois|    publicly traded|                        ABT|         pharmaceuticals|            pharmaceuticals|Extracted from an...|                null|\n|Advanced Neuromod...| Abbott Laboratories|    $2,950,000|                      $0|                                               $2,950,000|        2007|    20070702|healthcare-relate...|HHS civil monetar...|kickbacks and bri...|The HHS Inspector...|            federal|agency action|Health & Human Se...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          Illinois|    publicly traded|                        ABT|         pharmaceuticals|            pharmaceuticals|https://oig.hhs.g...|                null|\n|Advanced Steriliz...|   Johnson & Johnson|      $136,800|                      $0|                                                 $136,800|        2014|    20140520|environment-relat...|environmental vio...|                null|The U.S. Environm...|            federal|agency action|Environmental Pro...|             civil|                 null| null|           null|                         null|              null|    California|      Irvine|                null| null|      null|                null|                 USA|        New Jersey|    publicly traded|                        JNJ|         pharmaceuticals|            pharmaceuticals|https://archive.e...|                null|\n|Advanced Steriliz...|   Johnson & Johnson|    $1,200,000|                      $0|                                               $1,200,000|        2013|    20131204|safety-related of...|drug or medical e...|                null|Settlement of a c...|            federal|agency action|Food and Drug Adm...|             civil|                 null| null|           null|                         null|              null|    California|      Irvine|                null| null|      null|                null|                 USA|        New Jersey|    publicly traded|                        JNJ|         pharmaceuticals|            pharmaceuticals|http://www.fda.go...|                null|\n|Alere San Diego Inc.| Abbott Laboratories|       $10,572|                      $0|                                                  $10,572|        2017|    20170309|employment-relate...|wage and hour vio...|Fair Labor Standa...|                null|            federal|agency action|Labor Department ...|             civil|                 null| null|        1813371|                         null|              null|    California|      Pomona|828 Towne Center Dr.|91767|      null|                null|                 USA|          Illinois|    publicly traded|                        ABT|         pharmaceuticals|            pharmaceuticals|July 23, 2017 dow...|Date and year are...|\n|       Allergan Inc.|              AbbVie|  $600,000,000|                      $0|                                             $600,000,000|        2010|    20100901|healthcare-relate...|off-label or unap...|                null|American pharmace...|            federal|agency action|Food and Drug Adm...|civil and criminal|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          Illinois|    publicly traded|                       ABBV|         pharmaceuticals|            pharmaceuticals|http://www.justic...|                null|\n|       Allergan Inc.|              AbbVie|   $15,000,000|                      $0|                                              $15,000,000|        2017|    20170117|  financial offenses|investor protecti...|                null|Allergan Inc. adm...|            federal|agency action|Securities and Ex...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          Illinois|    publicly traded|                       ABBV|         pharmaceuticals|            pharmaceuticals|https://www.sec.g...|                null|\n|       Alpharma Inc.|              Pfizer|   $42,500,000|                      $0|                                              $42,500,000|        2010|    20100316|government-contra...|False Claims Act ...|kickbacks and bri...|Alpharma Inc. agr...|            federal|agency action|Justice Departmen...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          New York|    publicly traded|                        PFE|         pharmaceuticals|            pharmaceuticals|https://www.justi...|                null|\n|      Alpharma, Inc.|              Pfizer|    $2,500,000|                      $0|                                               $2,500,000|        2004|    20040812|competition-relat...|price-fixing or a...|consumer protecti...|Generic drug manu...|            federal|agency action|Federal Trade Com...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          New York|    publicly traded|                        PFE|         pharmaceuticals|            pharmaceuticals|https://www.ftc.g...|                null|\n|American Pharmace...|Bristol-Myers Squibb|      $160,203|                      $0|                                                 $160,203|        2004|    20041226|employment-relate...|wage and hour vio...|Fair Labor Standa...|                null|            federal|agency action|Labor Department ...|             civil|                 null| null|        1379241|                         null|              null|      New York|Grand Island|                null|14072|     32541|32541: Pharmaceut...|                 USA|          New York|    publicly traded|                        BMY|         pharmaceuticals|            pharmaceuticals|March 7, 2017 dow...|Date and year are...|\n+--------------------+--------------------+--------------+------------------------+---------------------------------------------------------+------------+------------+--------------------+--------------------+--------------------+--------------------+-------------------+-------------+--------------------+------------------+---------------------+-----+---------------+-----------------------------+------------------+--------------+------------+--------------------+-----+----------+--------------------+--------------------+------------------+-------------------+---------------------------+------------------------+---------------------------+--------------------+--------------------+\nonly showing top 15 rows\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+--------------------+--------------------+--------------+------------------------+---------------------------------------------------------+------------+------------+--------------------+--------------------+--------------------+--------------------+-------------------+-------------+--------------------+------------------+---------------------+-----+---------------+-----------------------------+------------------+--------------+------------+--------------------+-----+----------+--------------------+--------------------+------------------+-------------------+---------------------------+------------------------+---------------------------+--------------------+--------------------+\n|             Company|      Parent_Company|Penalty_Amount|Subtraction_From_Penalty|Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting|Penalty_Year|Penalty_Date|       Offense_Group|     Primary_Offense|   Secondary_Offense|         Description|Level_of_Government|  Action_Type|              Agency|    Civil/Criminal|Prosecution_Agreement|Court|        Case_ID|Private_Litigation_Case_Title|Lawsuit_Resolution|Facility_State|        City|             Address|  Zip|NAICS_Code|   NAICS_Translation|HQ_Country_of_Parent|HQ_State_of_Parent|Ownership_Structure|Parent_Company_Stock_Ticker|Major_Industry_of_Parent|Specific_Industry_of_Parent|         Info_Source|               Notes|\n+--------------------+--------------------+--------------+------------------------+---------------------------------------------------------+------------+------------+--------------------+--------------------+--------------------+--------------------+-------------------+-------------+--------------------+------------------+---------------------+-----+---------------+-----------------------------+------------------+--------------+------------+--------------------+-----+----------+--------------------+--------------------+------------------+-------------------+---------------------------+------------------------+---------------------------+--------------------+--------------------+\n| Abbott Laboratories| Abbott Laboratories|    $5,475,000|                      $0|                                               $5,475,000|        2013|    20131227|government-contra...|False Claims Act ...|kickbacks and bri...|Abbott Laboratori...|            federal|agency action|Justice Departmen...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          Illinois|    publicly traded|                        ABT|         pharmaceuticals|            pharmaceuticals|https://www.justi...|                null|\n|Abbott Laboratori...|              AbbVie|$1,500,000,000|                      $0|                                           $1,500,000,000|        2012|    20120507|healthcare-relate...|off-label or unap...|                null|Global Health Car...|            federal|agency action|Food and Drug Adm...|civil and criminal|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          Illinois|    publicly traded|                       ABBV|         pharmaceuticals|            pharmaceuticals|http://www.justic...|                null|\n|Abbott Laboratori...|              AbbVie|  $126,500,000|                      $0|                                             $126,500,000|        2010|    20101207|government-contra...|False Claims Act ...|                null|Abbott Laboratori...|            federal|agency action|Justice Departmen...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          Illinois|    publicly traded|                       ABBV|         pharmaceuticals|            pharmaceuticals|https://www.justi...|                null|\n|Abbott Laboratori...| Abbott Laboratories|       $49,045|                      $0|                                                  $49,045|        2009|    20090305|employment-relate...|wage and hour vio...|Fair Labor Standa...|                null|            federal|agency action|Labor Department ...|             civil|                 null| null|        1527129|                         null|              null|   Puerto Rico|    San Juan|                null| null|    423450|423450: Medical, ...|                 USA|          Illinois|    publicly traded|                        ABT|         pharmaceuticals|            pharmaceuticals|March 7, 2017 dow...|Date and year are...|\n|      Acclarent Inc.|   Johnson & Johnson|   $18,000,000|                      $0|                                              $18,000,000|        2016|    20160722|government-contra...|False Claims Act ...|                null|California-based ...|            federal|agency action|Justice Departmen...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|        New Jersey|    publicly traded|                        JNJ|         pharmaceuticals|            pharmaceuticals|https://www.justi...|                null|\n|Advanced Medical ...| Abbott Laboratories|       $16,800|                      $0|                                                  $16,800|        2004|    20040412|employment-relate...|labor relations v...|                null|back pay award in...|            federal|agency action|National Labor Re...|             civil|                 null| null|21-CA-36104-001|                         null|              null|    California|      Irvine|                null|92606|    333314|333314: Optical I...|                 USA|          Illinois|    publicly traded|                        ABT|         pharmaceuticals|            pharmaceuticals|Extracted from an...|                null|\n|Advanced Neuromod...| Abbott Laboratories|    $2,950,000|                      $0|                                               $2,950,000|        2007|    20070702|healthcare-relate...|HHS civil monetar...|kickbacks and bri...|The HHS Inspector...|            federal|agency action|Health & Human Se...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          Illinois|    publicly traded|                        ABT|         pharmaceuticals|            pharmaceuticals|https://oig.hhs.g...|                null|\n|Advanced Steriliz...|   Johnson & Johnson|      $136,800|                      $0|                                                 $136,800|        2014|    20140520|environment-relat...|environmental vio...|                null|The U.S. Environm...|            federal|agency action|Environmental Pro...|             civil|                 null| null|           null|                         null|              null|    California|      Irvine|                null| null|      null|                null|                 USA|        New Jersey|    publicly traded|                        JNJ|         pharmaceuticals|            pharmaceuticals|https://archive.e...|                null|\n|Advanced Steriliz...|   Johnson & Johnson|    $1,200,000|                      $0|                                               $1,200,000|        2013|    20131204|safety-related of...|drug or medical e...|                null|Settlement of a c...|            federal|agency action|Food and Drug Adm...|             civil|                 null| null|           null|                         null|              null|    California|      Irvine|                null| null|      null|                null|                 USA|        New Jersey|    publicly traded|                        JNJ|         pharmaceuticals|            pharmaceuticals|http://www.fda.go...|                null|\n|Alere San Diego Inc.| Abbott Laboratories|       $10,572|                      $0|                                                  $10,572|        2017|    20170309|employment-relate...|wage and hour vio...|Fair Labor Standa...|                null|            federal|agency action|Labor Department ...|             civil|                 null| null|        1813371|                         null|              null|    California|      Pomona|828 Towne Center Dr.|91767|      null|                null|                 USA|          Illinois|    publicly traded|                        ABT|         pharmaceuticals|            pharmaceuticals|July 23, 2017 dow...|Date and year are...|\n|       Allergan Inc.|              AbbVie|  $600,000,000|                      $0|                                             $600,000,000|        2010|    20100901|healthcare-relate...|off-label or unap...|                null|American pharmace...|            federal|agency action|Food and Drug Adm...|civil and criminal|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          Illinois|    publicly traded|                       ABBV|         pharmaceuticals|            pharmaceuticals|http://www.justic...|                null|\n|       Allergan Inc.|              AbbVie|   $15,000,000|                      $0|                                              $15,000,000|        2017|    20170117|  financial offenses|investor protecti...|                null|Allergan Inc. adm...|            federal|agency action|Securities and Ex...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          Illinois|    publicly traded|                       ABBV|         pharmaceuticals|            pharmaceuticals|https://www.sec.g...|                null|\n|       Alpharma Inc.|              Pfizer|   $42,500,000|                      $0|                                              $42,500,000|        2010|    20100316|government-contra...|False Claims Act ...|kickbacks and bri...|Alpharma Inc. agr...|            federal|agency action|Justice Departmen...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          New York|    publicly traded|                        PFE|         pharmaceuticals|            pharmaceuticals|https://www.justi...|                null|\n|      Alpharma, Inc.|              Pfizer|    $2,500,000|                      $0|                                               $2,500,000|        2004|    20040812|competition-relat...|price-fixing or a...|consumer protecti...|Generic drug manu...|            federal|agency action|Federal Trade Com...|             civil|                 null| null|           null|                         null|              null|          null|        null|                null| null|      null|                null|                 USA|          New York|    publicly traded|                        PFE|         pharmaceuticals|            pharmaceuticals|https://www.ftc.g...|                null|\n|American Pharmace...|Bristol-Myers Squibb|      $160,203|                      $0|                                                 $160,203|        2004|    20041226|employment-relate...|wage and hour vio...|Fair Labor Standa...|                null|            federal|agency action|Labor Department ...|             civil|                 null| null|        1379241|                         null|              null|      New York|Grand Island|                null|14072|     32541|32541: Pharmaceut...|                 USA|          New York|    publicly traded|                        BMY|         pharmaceuticals|            pharmaceuticals|March 7, 2017 dow...|Date and year are...|\n+--------------------+--------------------+--------------+------------------------+---------------------------------------------------------+------------+------------+--------------------+--------------------+--------------------+--------------------+-------------------+-------------+--------------------+------------------+---------------------+-----+---------------+-----------------------------+------------------+--------------+------------+--------------------+-----+----------+--------------------+--------------------+------------------+-------------------+---------------------------+------------------------+---------------------------+--------------------+--------------------+\nonly showing top 15 rows\n\n"]}}],"execution_count":0},{"cell_type":"code","source":["AddSponsorDF1 = myDataFrame.join(SponsorDF, myDataFrame.Sponsor == SponsorDF.Parent_Company,'left')"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"a3995f03-0327-4e7b-913d-384e18326127"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["AddSponsorDF1.show(2)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"f8fab0a2-5cd8-4870-885c-5722395ca19c"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+-----------+--------------------+----------+--------+----------+--------------+----------+--------------------+-------------+-------+--------------+--------------+------------------------+---------------------------------------------------------+------------+------------+-------------+---------------+-----------------+-----------+-------------------+-----------+------+--------------+---------------------+-----+-------+-----------------------------+------------------+--------------+----+-------+----+----------+-----------------+--------------------+------------------+-------------------+---------------------------+------------------------+---------------------------+-----------+-----+\n|         Id|             Sponsor|    Status|   Start|Completion|          Type|Submission|          Conditions|Interventions|Company|Parent_Company|Penalty_Amount|Subtraction_From_Penalty|Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting|Penalty_Year|Penalty_Date|Offense_Group|Primary_Offense|Secondary_Offense|Description|Level_of_Government|Action_Type|Agency|Civil/Criminal|Prosecution_Agreement|Court|Case_ID|Private_Litigation_Case_Title|Lawsuit_Resolution|Facility_State|City|Address| Zip|NAICS_Code|NAICS_Translation|HQ_Country_of_Parent|HQ_State_of_Parent|Ownership_Structure|Parent_Company_Stock_Ticker|Major_Industry_of_Parent|Specific_Industry_of_Parent|Info_Source|Notes|\n+-----------+--------------------+----------+--------+----------+--------------+----------+--------------------+-------------+-------+--------------+--------------+------------------------+---------------------------------------------------------+------------+------------+-------------+---------------+-----------------+-----------+-------------------+-----------+------+--------------+---------------------+-----+-------+-----------------------------+------------------+--------------+----+-------+----+----------+-----------------+--------------------+------------------+-------------------+---------------------------+------------------------+---------------------------+-----------+-----+\n|NCT02758028|The University of...|Recruiting|Aug 2005|  Nov 2021|Interventional|  Apr 2016|                null|         null|   null|          null|          null|                    null|                                                     null|        null|        null|         null|           null|             null|       null|               null|       null|  null|          null|                 null| null|   null|                         null|              null|          null|null|   null|null|      null|             null|                null|              null|               null|                       null|                    null|                       null|       null| null|\n|NCT02751957|     Duke University| Completed|Jul 2016|  Jul 2020|Interventional|  Apr 2016|Autistic Disorder...|         null|   null|          null|          null|                    null|                                                     null|        null|        null|         null|           null|             null|       null|               null|       null|  null|          null|                 null| null|   null|                         null|              null|          null|null|   null|null|      null|             null|                null|              null|               null|                       null|                    null|                       null|       null| null|\n+-----------+--------------------+----------+--------+----------+--------------+----------+--------------------+-------------+-------+--------------+--------------+------------------------+---------------------------------------------------------+------------+------------+-------------+---------------+-----------------+-----------+-------------------+-----------+------+--------------+---------------------+-----+-------+-----------------------------+------------------+--------------+----+-------+----+----------+-----------------+--------------------+------------------+-------------------+---------------------------+------------------------+---------------------------+-----------+-----+\nonly showing top 2 rows\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+-----------+--------------------+----------+--------+----------+--------------+----------+--------------------+-------------+-------+--------------+--------------+------------------------+---------------------------------------------------------+------------+------------+-------------+---------------+-----------------+-----------+-------------------+-----------+------+--------------+---------------------+-----+-------+-----------------------------+------------------+--------------+----+-------+----+----------+-----------------+--------------------+------------------+-------------------+---------------------------+------------------------+---------------------------+-----------+-----+\n|         Id|             Sponsor|    Status|   Start|Completion|          Type|Submission|          Conditions|Interventions|Company|Parent_Company|Penalty_Amount|Subtraction_From_Penalty|Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting|Penalty_Year|Penalty_Date|Offense_Group|Primary_Offense|Secondary_Offense|Description|Level_of_Government|Action_Type|Agency|Civil/Criminal|Prosecution_Agreement|Court|Case_ID|Private_Litigation_Case_Title|Lawsuit_Resolution|Facility_State|City|Address| Zip|NAICS_Code|NAICS_Translation|HQ_Country_of_Parent|HQ_State_of_Parent|Ownership_Structure|Parent_Company_Stock_Ticker|Major_Industry_of_Parent|Specific_Industry_of_Parent|Info_Source|Notes|\n+-----------+--------------------+----------+--------+----------+--------------+----------+--------------------+-------------+-------+--------------+--------------+------------------------+---------------------------------------------------------+------------+------------+-------------+---------------+-----------------+-----------+-------------------+-----------+------+--------------+---------------------+-----+-------+-----------------------------+------------------+--------------+----+-------+----+----------+-----------------+--------------------+------------------+-------------------+---------------------------+------------------------+---------------------------+-----------+-----+\n|NCT02758028|The University of...|Recruiting|Aug 2005|  Nov 2021|Interventional|  Apr 2016|                null|         null|   null|          null|          null|                    null|                                                     null|        null|        null|         null|           null|             null|       null|               null|       null|  null|          null|                 null| null|   null|                         null|              null|          null|null|   null|null|      null|             null|                null|              null|               null|                       null|                    null|                       null|       null| null|\n|NCT02751957|     Duke University| Completed|Jul 2016|  Jul 2020|Interventional|  Apr 2016|Autistic Disorder...|         null|   null|          null|          null|                    null|                                                     null|        null|        null|         null|           null|             null|       null|               null|       null|  null|          null|                 null| null|   null|                         null|              null|          null|null|   null|null|      null|             null|                null|              null|               null|                       null|                    null|                       null|       null| null|\n+-----------+--------------------+----------+--------+----------+--------------+----------+--------------------+-------------+-------+--------------+--------------+------------------------+---------------------------------------------------------+------------+------------+-------------+---------------+-----------------+-----------+-------------------+-----------+------+--------------+---------------------+-----+-------+-----------------------------+------------------+--------------+----+-------+----+----------+-----------------+--------------------+------------------+-------------------+---------------------------+------------------------+---------------------------+-----------+-----+\nonly showing top 2 rows\n\n"]}}],"execution_count":0},{"cell_type":"code","source":["AddSponsorDF2 = AddSponsorDF1.select('Sponsor','Parent_Company' ).where ('Parent_Company is null').groupBy(['Sponsor']).count().orderBy(['count'],ascending = False)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"2c03c8a3-c308-4a07-8091-c9300a59aecf"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["AddSponsorDF2.show(10)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"eb9c5405-911e-44b9-9a20-0b8fbd058a1a"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+--------------------+-----+\n|             Sponsor|count|\n+--------------------+-----+\n|National Cancer I...| 3218|\n|M.D. Anderson Can...| 2414|\n|Assistance Publiq...| 2369|\n|         Mayo Clinic| 2300|\n|Merck Sharp & Doh...| 2243|\n|   Assiut University| 2154|\n|Novartis Pharmace...| 2088|\n|Massachusetts Gen...| 1971|\n|    Cairo University| 1928|\n|   Hoffmann-La Roche| 1828|\n+--------------------+-----+\nonly showing top 10 rows\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+--------------------+-----+\n|             Sponsor|count|\n+--------------------+-----+\n|National Cancer I...| 3218|\n|M.D. Anderson Can...| 2414|\n|Assistance Publiq...| 2369|\n|         Mayo Clinic| 2300|\n|Merck Sharp & Doh...| 2243|\n|   Assiut University| 2154|\n|Novartis Pharmace...| 2088|\n|Massachusetts Gen...| 1971|\n|    Cairo University| 1928|\n|   Hoffmann-La Roche| 1828|\n+--------------------+-----+\nonly showing top 10 rows\n\n"]}}],"execution_count":0},{"cell_type":"markdown","source":["STUDIES COMPLETED BY MONTH"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"d2dcc0cf-7cb7-415f-b1e9-aec1bf8d6bca"}}},{"cell_type":"code","source":["StudCompMon = myDataFrame.filter(myDataFrame.Completion.endswith('2021')).filter(myDataFrame.Status=='Completed').groupBy('Completion').count().sort(desc('count'))"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"8b9473b7-f59b-4330-bbe0-3470400c592f"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["StudCompMon1= StudCompMon.orderBy('Completion').withColumn('Completion',split(col('Completion'),' ').getItem(0)).sort('Completion', inplace= True)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"e75250e7-be72-4f85-b0ed-9359e9b489c0"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["from pyspark.sql.functions  import unix_timestamp\nStudCompMon2=StudCompMon1.sort(unix_timestamp(col('Completion'),\"MMM\"))"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"cfad1c0d-3918-447a-a61a-cd469a799e99"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["StudCompMon2.show()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"2d02c4a6-6f5f-4967-83cf-eafffc80d576"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+----------+-----+\n|Completion|count|\n+----------+-----+\n|       Jan| 1131|\n|       Feb|  934|\n|       Mar| 1227|\n|       Apr|  967|\n|       May|  984|\n|       Jun| 1094|\n|       Jul|  819|\n|       Aug|  700|\n|       Sep|  528|\n|       Oct|  187|\n+----------+-----+\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+----------+-----+\n|Completion|count|\n+----------+-----+\n|       Jan| 1131|\n|       Feb|  934|\n|       Mar| 1227|\n|       Apr|  967|\n|       May|  984|\n|       Jun| 1094|\n|       Jul|  819|\n|       Aug|  700|\n|       Sep|  528|\n|       Oct|  187|\n+----------+-----+\n\n"]}}],"execution_count":0},{"cell_type":"code","source":["StudCompMon2.toPandas().plot.bar(x='Completion',y='count', color= 'red' )"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"ff46c203-506f-4f5e-aa48-14bc9b74d1f4"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"Out[81]: <AxesSubplot:xlabel='Completion'>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["Out[81]: <AxesSubplot:xlabel='Completion'>"]}},{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"data:image/png;base64,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\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"image","arguments":{}}},"output_type":"display_data","data":{"image/png":"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\n"}}],"execution_count":0},{"cell_type":"markdown","source":["finding location where clinical sponsor are located and the count based on clinical sponsor on each location"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"29bfd458-0dc1-4ced-b0ec-6e89e21b9f9f"}}},{"cell_type":"code","source":["locationDF = SponsorDF.select(['Parent_Company','City']).filter(SponsorDF.City.isNotNull())"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"c8dabf5c-6b21-42b1-8403-caa94e93bd4c"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["sponsorcountdf= myDataFrame.select(['Sponsor']).groupBy('Sponsor').count()\nsponsorcountdf.show()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"b55d7f58-26a7-4b21-8582-14e5cdc6c5d3"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"+--------------------+-----+\n|             Sponsor|count|\n+--------------------+-----+\n|University Hospit...|  128|\n|Federal Universit...|   84|\n|Second Affiliated...|   17|\n|    Mosaic Life Care|    2|\n|Duke-NUS Graduate...|   48|\n|Beijing Neurosurg...|   11|\n|University of Okl...|  284|\n|Milton S. Hershey...|  384|\n|  Ryerson University|   45|\n|Mae Fah Luang Uni...|   14|\n|   Goethe University|   61|\n|The Ninth Hospita...|    1|\n|Guangzhou Univers...|   37|\n|Qazvin University...|   33|\n|  Aeris Therapeutics|   18|\n|   United Biomedical|    4|\n|University of Nov...|    6|\n|Alios Biopharma Inc.|   21|\n|Peter MacCallum C...|   53|\n|Bronx VA Medical ...|   14|\n+--------------------+-----+\nonly showing top 20 rows\n\n","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"ansi","arguments":{}}},"output_type":"display_data","data":{"text/plain":["+--------------------+-----+\n|             Sponsor|count|\n+--------------------+-----+\n|University Hospit...|  128|\n|Federal Universit...|   84|\n|Second Affiliated...|   17|\n|    Mosaic Life Care|    2|\n|Duke-NUS Graduate...|   48|\n|Beijing Neurosurg...|   11|\n|University of Okl...|  284|\n|Milton S. Hershey...|  384|\n|  Ryerson University|   45|\n|Mae Fah Luang Uni...|   14|\n|   Goethe University|   61|\n|The Ninth Hospita...|    1|\n|Guangzhou Univers...|   37|\n|Qazvin University...|   33|\n|  Aeris Therapeutics|   18|\n|   United Biomedical|    4|\n|University of Nov...|    6|\n|Alios Biopharma Inc.|   21|\n|Peter MacCallum C...|   53|\n|Bronx VA Medical ...|   14|\n+--------------------+-----+\nonly showing top 20 rows\n\n"]}}],"execution_count":0},{"cell_type":"code","source":["sponsorcountdf1=sponsorcountdf.join(locationDF, sponsorcountdf.Sponsor == locationDF.Parent_Company,'inner').select(['Sponsor','City','count'])"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"dc9db222-9710-4898-9a52-b0c52d2a61a4"}},"outputs":[],"execution_count":0},{"cell_type":"code","source":["\ngrouplocation = sponsorcountdf.join(locationDF, sponsorcountdf.Sponsor == locationDF.Parent_Company,'inner').select(['Sponsor','City','count'])"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"01b77789-16b3-4b48-8599-cb43e73fc5b3"}},"outputs":[],"execution_count":0},{"cell_type":"markdown","source":["######This shows pharmaceutical sponsor of clinical trial are located in more than one city and the numbers of there clinical trials.\nGlaxoSmithkline has the highest number."],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"7e7c3c4f-5796-46e4-875d-e0a378ef410e"}}},{"cell_type":"code","source":["grouplocation = sponsorcountdf.join(locationDF, sponsorcountdf.Sponsor == locationDF.Parent_Company,'inner').select(['Sponsor','City','count']).orderBy('count',ascending = False)\ngrouplocation.display(truncate = False)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"3b9ef62a-a8dc-40f2-9495-c46960a23870"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"overflow":false,"datasetInfos":[],"data":[["GlaxoSmithKline","Memphis",3378],["GlaxoSmithKline","Hamilton",3378],["GlaxoSmithKline","East Durham",3378],["GlaxoSmithKline","King of Prussia",3378],["GlaxoSmithKline","KING OF PRUSSIA",3378],["AstraZeneca","SMITHFIELD",2691],["AstraZeneca","SHEPHEDSVILLE",2691],["AstraZeneca","Wayne",2691],["Pfizer","Groton",2645],["Pfizer","Groton",2645],["Pfizer","BARCELONETA",2645],["Pfizer","McPherson",2645],["Pfizer","Andover",2645],["Pfizer","BRISTOL",2645],["Pfizer","BRISTOL",2645],["Pfizer","Groton",2645],["Pfizer","GUAYAMA",2645],["Pfizer","NORTH CHICAGO",2645],["Pfizer","AUSTIN",2645],["Pfizer","Barceloneta",2645],["Pfizer","ARECIBO",2645],["Pfizer","GROTON",2645],["Pfizer","GROTON",2645],["Pfizer","GUAYAMA",2645],["Pfizer","Barceloneta",2645],["Pfizer","Bristol",2645],["Boehringer Ingelheim","Ridgefield",1967],["Boehringer Ingelheim","St. Joseph",1967],["Sanofi","SWIFTWATER",1274],["Bristol-Myers Squibb","HUMACAO",1171],["Bristol-Myers Squibb","NORTH BRUNSWICK",1171],["Bristol-Myers Squibb","SUMMIT",1171],["Bristol-Myers Squibb","NEW YORK",1171],["Bristol-Myers Squibb","Wallingford",1171],["Bristol-Myers Squibb","LAWRENCEVILLE",1171],["Bristol-Myers Squibb","Grand Island",1171],["Amgen","West Greenwich",744],["Amgen","Cambridge",744],["Amgen","Cambridge",744],["Amgen","THOUSAND OAKS",744],["Amgen","SOUTH SAN FRANCISCO",744],["Amgen","St. Louis",744],["Novartis","EMERYVILLE",690],["Novartis","LINCOLN",690],["Novartis","LINCOLN",690],["Novartis","GREENSBORO",690],["Gilead Sciences","FOSTER CITY",563],["AbbVie","Grand Island",525],["AbbVie","GURNEE",525],["AbbVie","CARMEL",525],["Mallinckrodt","Hobart",86],["Mallinckrodt","Hazelwood",86],["Mallinckrodt","LA FAYETTE",86],["Mallinckrodt","HOBART",86],["Mallinckrodt","ST. LOUIS",86],["Mallinckrodt","ST. LOUIS",86],["Teva Pharmaceutical Industries","IRVINE",80],["Teva Pharmaceutical Industries","ELMWOOD PARK",80],["Teva Pharmaceutical Industries","MEXICO",80],["Teva Pharmaceutical Industries","CINCINNATI",80],["Teva Pharmaceutical Industries","CINCINNATI",80],["Teva Pharmaceutical Industries","Mexico",80],["Teva Pharmaceutical Industries","EAST HANOVER",80],["Teva Pharmaceutical Industries","N MIAMI BEACH",80],["Teva Pharmaceutical Industries","Mexico",80],["Teva Pharmaceutical Industries","CINCINNATI",80],["Teva Pharmaceutical Industries","SELLERSVILLE",80],["Teva Pharmaceutical Industries","POMONA",80],["Teva Pharmaceutical Industries","Mexico",80],["Teva Pharmaceutical Industries","MEXICO",80],["CSL Limited","MARGATE",10]],"plotOptions":{"displayType":"table","customPlotOptions":{},"pivotColumns":null,"pivotAggregation":null,"xColumns":null,"yColumns":null},"columnCustomDisplayInfos":{},"aggType":"","isJsonSchema":true,"removedWidgets":[],"aggSchema":[],"schema":[{"name":"Sponsor","type":"\"string\"","metadata":"{}"},{"name":"City","type":"\"string\"","metadata":"{}"},{"name":"count","type":"\"long\"","metadata":"{}"}],"aggError":"","aggData":[],"addedWidgets":{},"metadata":{},"dbfsResultPath":null,"type":"table","aggOverflow":false,"aggSeriesLimitReached":false,"arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .table-result-container {\n    max-height: 300px;\n    overflow: auto;\n  }\n  table, th, td {\n    border: 1px solid black;\n    border-collapse: collapse;\n  }\n  th, td {\n    padding: 5px;\n  }\n  th {\n    text-align: left;\n  }\n</style><div class='table-result-container'><table class='table-result'><thead style='background-color: white'><tr><th>Sponsor</th><th>City</th><th>count</th></tr></thead><tbody><tr><td>GlaxoSmithKline</td><td>Memphis</td><td>3378</td></tr><tr><td>GlaxoSmithKline</td><td>Hamilton</td><td>3378</td></tr><tr><td>GlaxoSmithKline</td><td>East Durham</td><td>3378</td></tr><tr><td>GlaxoSmithKline</td><td>King of Prussia</td><td>3378</td></tr><tr><td>GlaxoSmithKline</td><td>KING OF PRUSSIA</td><td>3378</td></tr><tr><td>AstraZeneca</td><td>SMITHFIELD</td><td>2691</td></tr><tr><td>AstraZeneca</td><td>SHEPHEDSVILLE</td><td>2691</td></tr><tr><td>AstraZeneca</td><td>Wayne</td><td>2691</td></tr><tr><td>Pfizer</td><td>Groton</td><td>2645</td></tr><tr><td>Pfizer</td><td>Groton</td><td>2645</td></tr><tr><td>Pfizer</td><td>BARCELONETA</td><td>2645</td></tr><tr><td>Pfizer</td><td>McPherson</td><td>2645</td></tr><tr><td>Pfizer</td><td>Andover</td><td>2645</td></tr><tr><td>Pfizer</td><td>BRISTOL</td><td>2645</td></tr><tr><td>Pfizer</td><td>BRISTOL</td><td>2645</td></tr><tr><td>Pfizer</td><td>Groton</td><td>2645</td></tr><tr><td>Pfizer</td><td>GUAYAMA</td><td>2645</td></tr><tr><td>Pfizer</td><td>NORTH CHICAGO</td><td>2645</td></tr><tr><td>Pfizer</td><td>AUSTIN</td><td>2645</td></tr><tr><td>Pfizer</td><td>Barceloneta</td><td>2645</td></tr><tr><td>Pfizer</td><td>ARECIBO</td><td>2645</td></tr><tr><td>Pfizer</td><td>GROTON</td><td>2645</td></tr><tr><td>Pfizer</td><td>GROTON</td><td>2645</td></tr><tr><td>Pfizer</td><td>GUAYAMA</td><td>2645</td></tr><tr><td>Pfizer</td><td>Barceloneta</td><td>2645</td></tr><tr><td>Pfizer</td><td>Bristol</td><td>2645</td></tr><tr><td>Boehringer Ingelheim</td><td>Ridgefield</td><td>1967</td></tr><tr><td>Boehringer Ingelheim</td><td>St. Joseph</td><td>1967</td></tr><tr><td>Sanofi</td><td>SWIFTWATER</td><td>1274</td></tr><tr><td>Bristol-Myers Squibb</td><td>HUMACAO</td><td>1171</td></tr><tr><td>Bristol-Myers Squibb</td><td>NORTH BRUNSWICK</td><td>1171</td></tr><tr><td>Bristol-Myers Squibb</td><td>SUMMIT</td><td>1171</td></tr><tr><td>Bristol-Myers Squibb</td><td>NEW YORK</td><td>1171</td></tr><tr><td>Bristol-Myers Squibb</td><td>Wallingford</td><td>1171</td></tr><tr><td>Bristol-Myers Squibb</td><td>LAWRENCEVILLE</td><td>1171</td></tr><tr><td>Bristol-Myers Squibb</td><td>Grand Island</td><td>1171</td></tr><tr><td>Amgen</td><td>West Greenwich</td><td>744</td></tr><tr><td>Amgen</td><td>Cambridge</td><td>744</td></tr><tr><td>Amgen</td><td>Cambridge</td><td>744</td></tr><tr><td>Amgen</td><td>THOUSAND OAKS</td><td>744</td></tr><tr><td>Amgen</td><td>SOUTH SAN FRANCISCO</td><td>744</td></tr><tr><td>Amgen</td><td>St. Louis</td><td>744</td></tr><tr><td>Novartis</td><td>EMERYVILLE</td><td>690</td></tr><tr><td>Novartis</td><td>LINCOLN</td><td>690</td></tr><tr><td>Novartis</td><td>LINCOLN</td><td>690</td></tr><tr><td>Novartis</td><td>GREENSBORO</td><td>690</td></tr><tr><td>Gilead Sciences</td><td>FOSTER CITY</td><td>563</td></tr><tr><td>AbbVie</td><td>Grand Island</td><td>525</td></tr><tr><td>AbbVie</td><td>GURNEE</td><td>525</td></tr><tr><td>AbbVie</td><td>CARMEL</td><td>525</td></tr><tr><td>Mallinckrodt</td><td>Hobart</td><td>86</td></tr><tr><td>Mallinckrodt</td><td>Hazelwood</td><td>86</td></tr><tr><td>Mallinckrodt</td><td>LA FAYETTE</td><td>86</td></tr><tr><td>Mallinckrodt</td><td>HOBART</td><td>86</td></tr><tr><td>Mallinckrodt</td><td>ST. LOUIS</td><td>86</td></tr><tr><td>Mallinckrodt</td><td>ST. LOUIS</td><td>86</td></tr><tr><td>Teva Pharmaceutical Industries</td><td>IRVINE</td><td>80</td></tr><tr><td>Teva Pharmaceutical Industries</td><td>ELMWOOD PARK</td><td>80</td></tr><tr><td>Teva Pharmaceutical Industries</td><td>MEXICO</td><td>80</td></tr><tr><td>Teva Pharmaceutical Industries</td><td>CINCINNATI</td><td>80</td></tr><tr><td>Teva Pharmaceutical Industries</td><td>CINCINNATI</td><td>80</td></tr><tr><td>Teva Pharmaceutical Industries</td><td>Mexico</td><td>80</td></tr><tr><td>Teva Pharmaceutical Industries</td><td>EAST HANOVER</td><td>80</td></tr><tr><td>Teva Pharmaceutical Industries</td><td>N MIAMI BEACH</td><td>80</td></tr><tr><td>Teva Pharmaceutical Industries</td><td>Mexico</td><td>80</td></tr><tr><td>Teva Pharmaceutical Industries</td><td>CINCINNATI</td><td>80</td></tr><tr><td>Teva Pharmaceutical Industries</td><td>SELLERSVILLE</td><td>80</td></tr><tr><td>Teva Pharmaceutical Industries</td><td>POMONA</td><td>80</td></tr><tr><td>Teva Pharmaceutical Industries</td><td>Mexico</td><td>80</td></tr><tr><td>Teva Pharmaceutical Industries</td><td>MEXICO</td><td>80</td></tr><tr><td>CSL Limited</td><td>MARGATE</td><td>10</td></tr></tbody></table></div>"]}}],"execution_count":0},{"cell_type":"code","source":[""],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"a07a2a4c-5e13-48a7-bc00-4a0292638d6e"}},"outputs":[],"execution_count":0}],"metadata":{"application/vnd.databricks.v1+notebook":{"notebookName":"YUSUF-BANIRE _DF","dashboards":[],"notebookMetadata":{"pythonIndentUnit":4},"language":"python","widgets":{},"notebookOrigID":661741556146256}},"nbformat":4,"nbformat_minor":0}
